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Abstract
THE ROLE OF THE Ca2+-DEPENDENT PROTEIN KINASE, CAMK-II, IN HEART AND
KIDNEY DEVELOPMENT IN THE ZEBRAFISH, DANIO RERIO
By Sarah Chase Rothschild, B.A.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2010
Robert M. Tombes, Ph.D.
Professor of Biology
Ca2+/calmodulin-dependent protein kinase type II (CaMK-II) is a multifunctional
serine/threonine kinase that is ubiquitously expressed throughout the lifespan of metazoans.
Mammals encode four genes (α, β, γ, δ) that generate over forty splice-variants. CaMK-II is
important in a myriad of functions, including ion channel regulation, cell-cycle progression, and
long term potentiation. In adults, alterations in activation of CaMK-II induce cardiac arrhythmias
and heart failure. Developmental roles for CaMK-II are not as well understood since mouse
knockouts are embryonic lethal. Therefore the identification of other vertebrate CaMK-II genes
will add to our understanding of development. Zebrafish encode seven catalytically active
CaMK-II genes (α1, β1, β2, γ1, γ2, δ1, δ2) due to a genome wide duplication event that occurred
approximately 250 million years ago. Although, only 20-30% of all duplicated genes were
retained, 75% of CaMK-II duplicated genes are transcriptionally active, pointing to a critical role
for this signaling protein. mRNA expression patterns demonstrate that CaMK-II is expressed in
diverse tissues including retina, pectoral fins, somites, heart, and kidney. Suppression of each
xvi
gene generates unique phenotypes that mirror the mRNA expression patterns. Of the seven
genes, camk2b2 and camk2g1 have the highest maternal contribution in zebrafish, are expressed
in mesodermally derived organs, and develop defects similar to human syndromes.  In fact,
suppression of camk2b2 mimics the phenotype observed in zebrafish mutants of tbx5, the gene
mutated in patients with Holt-Oram Syndrome. Camk2g1 morphants also exhibit similar defects
as suppression of pkd2, the gene mutated in patients with Autosomal Dominant Polycystic
Kidney disease. These roles implicate CaMK-II as an integral protein in the development and
maintenance of mesodermally derived tissues.
1Chapter 1: Background
Ca2+ and Development
Ca2+ is an integral second messenger at fertilization, during development, and throughout
adulthood. Ca2+ is required for cell proliferation, cell differentiation, pattern formation, axis
determination, organ development, and thus, formation of the overall body plan in vertebrates
(Whitaker, 2006). The activity of Ca2+ dependent proteins is determined by the amplitude,
frequency, and duration of the Ca2+ stimulus, which can then be translated into a cellular
response (Schulman et al., 1992; Whitaker, 2006).
At fertilization, sperm-egg fusion generates a propagating Ca2+ wave from intracellular
stores that induces egg activation (Whitaker and Steinhardt, 1982). This Ca2+ wave is involved in
many essential early processes such as cortical granule (CG) exocytosis, cytoskeletal
rearrangements, and cell-cycle progression (Abbott and Ducibella, 2001; Lorca et al., 1993;
Stemmann et al., 2001; Tatone et al., 2002; Tatone et al., 1999; Tombes et al., 1991). In the
mammalian egg, CG exocytosis begins about 5-10 minutes after insemination, but it takes
approximately 45-60 minutes to be completed (Tahara et al., 1996). This is due to the duration of
intracellular Ca2+ elevations necessary to activate downstream effector proteins, which have been
demonstrated to positively regulate the level of CG exocytosis (Abbott and Ducibella, 2001).
Continued Ca2+ oscillations are also required for metaphase II exit, where the anaphase
promoting complex is activated, cyclin B is degraded and sister chromatids separate (Lorca et al.,
1993; Markoulaki et al., 2003; Markoulaki et al., 2004; Nixon et al., 2002).  Although both CG
2exocytosis and metaphase II exit require Ca2+ oscillations, the amplitude and duration of Ca2+
differentially activate effector proteins to drive these cellular mechanisms.
At the single cell stage Ca2+ waves are present to initiate cleavage furrow positioning,
generation of the contractile ring, and membrane additions as the furrow deepens, which
ultimately leads to cytokinesis (Chang and Lu, 2000; Webb and Miller, 2000). A series of cell
divisions then occur to generate the blastocyst, relying heavily on maternal stores of proteins and
mRNAs since zygotic transcription does not occur until the midblastula transition (MBT).
As the embryo develops the cellular pathways become more complex and the need for
both intracellular and intercellular Ca2+ is evident. At gastrulation a process known as
convergence and extension occurs, where cells migrate toward the midline dorsally and
intercalate through an anteriorward elongation (Bakkers et al., 2004; Keller and Danilchik, 1988;
Myers et al., 2002). This process determines the anterior-posterior axis of the embryo and is
largely dependent on Ca2+ and “non-canonical” Wnt (ncWnt) family members (Wallingford et
al., 2001). ncWnts act in a β-catenin independent manner and function to release Ca2+ stores
from the ER through phospholipase C to activate effector proteins, such as CaMK-II and PKC,
causing cells to undergo cytoskeletal reorganization and shape changes to maintain proper
polarity during migration. Well characterized non-canonical Wnts, Wnt5 and Wnt11, are
necessary for proper cell movements during gastrulation. Suppression of Wnt5, Wnt11, or
CaMK-II (Tombes lab unpublished data) during embryogenesis leads to anterior-posterior axis
defects, including compressed somites and an undulated notochord (Kuhl et al., 2001; Roszko et
al., 2009; Sheldahl et al., 2003).
Continued Ca2+ elevations are found during the segmentation period where Ca2+ is
necessary to form somites, eyes, and establish organ left-right asymmetry (Brady and Hilfer,
31982; Creton et al., 1998; Shimeld, 2004; Webb and Miller, 2006). Recent work in the Tombes
lab has identified three zebrafish CaMK-II genes required for left-right asymmetry, where
CaMK-II acts as the downstream target of PKD2 Ca2+ in the Kupffer’s vesicle (KV), thus
generating sided expression of downstream targets.  Zebrafish embryos that were injected with f-
aequorin, a calcium-sensitive bioluminescent protein, and imaged have four main intercellular
calcium pulses (Shimomura et al., 1990). There is a tail bud pulse at 90% epiboly, a brain pulse
at bud stage, a trunk pulse at 6 somites, and an eye pulse at 10 somites.  Each intercellular Ca2+
pulse is generated in a region where the formation of major structures is about to occur (Creton
et al., 1998; Webb and Miller, 2000).  Similar Ca2+ pulses are thought to exist in other species.
Chick embryos treated with the Ca2+ ionophore, A23187, form somites, however, verapamil a
Ca2+ channel antagonist inhibits segmentation (Chernoff and Hilfer, 1982).
Once the body plan of the embryo is established, localized Ca2+ elevations facilitate the
development of organs, such as the heart and kidney. Although Ca2+ is well established in the
heart as an important second messenger during cardiac contractions, researchers are now
demonstrating that Ca2+ is also essential in rudimentary heart development. Zebrafish embryos
injected with BAPTA develop a linear heart that is unable to pump blood and has an enlarged
pericardial sac (Creton et al., 1998). Suppression of CaMK-II in zebrafish yields a similar
phenotype whereby the heart fails to undergo looping and blood circulation is reduced
(Rothschild et al., 2009). Ca2+ is also important in kidney development and homeostasis.
Suppression of PKD2, a nonselective Ca2+ channel, induces kidney cysts in zebrafish and mice,
and mutations in PKD2 leads to Autosomal Dominant Polycystic Kidney disease (ADPKD) (Lu
et al., 2001; Obara et al., 2006; Piontek et al., 2004; Schottenfeld et al., 2007; Wilson, 2004a;
Wilson, 2008). The target of PKD2 Ca2+ in the kidney remains to be elucidated. In addition,
4Annexin IV, a Ca2+-dependent phospholipid binding protein, has been shown to be important in
Xenopus pronephros development, where suppression causes an enlarged and shortened
pronephric tubule (Seville et al., 2002).
Embryonic development is dependent on Ca2+ and Ca2+-dependent proteins to activate
intracellular pathways. Alterations in Ca2+ signaling can lead to varied conditions such as
heterotaxia, ADPKD, and heart failure. Although many model systems have been used to study
Ca2+ signaling, zebrafish have become an attractive and valuable vertebrate model due to the
wide variety of suppression methods and imaging techniques. Identifying the effectors of Ca2+
will help scientists to better understand organ placement, find treatments for cystic kidney
diseases, and understand the causes of heart disease.
Zebrafish (Brachydanio rerio) as a Model System:
 Zebrafish have become a very attractive model system to study genetics and
development.  Zebrafish mutants mimic human syndromes allowing researchers to delve into the
pathogenesis of diseases in hopes of generating viable treatments. Although many model systems
are used in research, zebrafish are moving to the forefront due to the similarity in cellular
signaling that occurs during embryogenesis.
The use of zebrafish as an experimental organism began in the late 1970s at the
University of Oregon, where George Streisinger recognized the strength of this small vertebrate
in understanding both development and genetics. Zebrafish are a freshwater fish, indigenous to
the rivers and streams in India and can also be found in your local pet store. Due to its short
generation time (3 months), external fertilization, large clutches, optical clarity, and rapid
development, zebrafish have become a well-established system in biological studies (Kimmel et
5al., 1995). Streisinger’s lab cloned zebrafish (Streisinger et al., 1981) and developed several
techniques to harness the zebrafish’s experimental potential including: mutagenesis (Grunwald
and Streisinger, 1992a; Grunwald and Streisinger, 1992b; Walker and Streisinger, 1983), genetic
mapping (Streisinger et al., 1986), and creation of genetic mosaics (Streisinger et al., 1989).
Sequencing the zebrafish genome began in 2001 at the Sanger Institute in England and is
approximately 80% complete as of 2010 (ensembl.org). Zebrafish have 25 chromosomes and are
thought to have undergone a genome-wide duplication event approximately 250 million years
ago. Overall approximately 20-30% of the duplicated genes were retained in the genome as
transcriptionally active genes (Postlethwait et al., 2004).
Zebrafish are a valuable model system because one can take advantage of both forward
(ENU treatment) and reverse genetic techniques (viral insertion, TILLING, zinc finger nucleases,
and antisense morpholino oligonucleotides). Traditional mutagenesis utilizes ENU treatment of
sperm, leading to a point mutation in the genome, and ultimately generating a developmental
phenotype (Grunwald and Streisinger, 1992b; Solnica-Krezel et al., 1994). Positional cloning can
be used to identify the site of the mutation therefore identifying a potential function for a specific
gene (Solnica-Krezel et al., 1994). A second technique involves insertional mutagenesis, where a
retroviral provirus is inserted into the genome causing a specific phenotype (Allende et al.,
1996). Sequencing is then used to identify the insertion site, therefore identifying the gene
responsible for the developmental defects. Targeting induced local lesion in genome (TILLING)
is a newer technique that allows the identification of a mutation in a gene of interest (Wienholds
et al., 2003). This technique generates mutants of a certain gene as opposed to linking
phenotypes to mutation in unknown genes. The newest technique involves the use of zinc finger
nucleases specifically designed against a sequence of interest allowing one to generate a
6mutation in the gene of interest. (Doyon et al., 2008). The primary reverse genetic technique is
the injection of antisense morpholino oligonucleotides (MO’s) into the embryo prior to the eight-
cell stage. MO’s are designed against a gene of interest to either inhibit translation or inhibit
proper splicing of exons. (Nasevicius and Ekker, 2000). This technique enables the investigator
to suppress the expression of a gene and determine which cellular processes require that gene.
The use of forward genetic techniques is well established but does have drawbacks where many
mutant alleles are not null but hypomorphic. One can establish a knockdown phenotype using
MO’s, however “off target” effects can occur. In addition, MO’s persist in the embryo for about
3dpf allowing an investigator to look at early developmental defects but not larval or adult
phenotypes. Still, the ability of investigators to use both forward and reverse techniques makes
this organism a very valuable model for studying vertebrate development.
In addition, zebrafish have become important in understanding the role Ca2+ plays during
embryogenesis. Techniques have been established to capture and visualize Ca2+ waves, through
microinjection of photoproteins, Ca2+ dyes, and genetically targeted fluorescent indicators (Ebert
et al., 2005; Palmer and Tsien, 2006; Shimomura et al., 1990).  Although zebrafish are not as
complex as humans, many of the same cellular signaling pathways are used during early
development. The transparency of the embryo, external development, and cell size allows the
study of Ca2+ signaling in vivo leading to the identification of downstream effectors, such as
CaMK-II and PKC.  These effectors are the mediators between the Ca2+ stimulus and cellular
response and may be the key to unlocking the mysteries of human syndromes.
7Ca2+/Calmodulin-Dependent Protein Kinase Type II: Structure and Function:
Ca2+/calmodulin-dependent protein kinase type II (CaMK-II) is the multifunctional
serine/threonine protein kinase that is encoded by four genes (α, β, γ, and δ), to generate over
forty splice variants in metazoans. CaMK-II hetero-oligomerizes to form dodecamers (twelve
monomers) and is activated once Ca2+/calmodulin (CaM) binds causing a conformational change
in the protein. The three domains that comprise each monomer include the catalytic, variable,
and oligomerization domains. The first 315-amino acids encode the catalytic domain and include
the CaM binding site, ATP binding pocket, and autoinhibitory arm (Schulman et al., 1992). The
autoinhibitory arm maintains CaMK-II in the basal state and upon Ca2+/CaM binding this
subdomain moves away from the catalytic site (Colbran et al., 1989). Alternative splicing within
the variable domain generates various splice variants that determine subcellular localization and
alterations in CaM binding affinity. The size of the variable domain can range from 30 to 100
amino acids. The oligomerization domain, also known as the association domain, facilitates
association into the correct dodecameric configuration (Tombes et al., 2003; Tombes and
Krystal, 1997).
CaMK-II is unlike other CaM kinases in that it hetero-oligomerizes and
autophosphorylates at Thr287 (Thr286 in α )  to allow for Ca2+ independent activity.
Autophosphorylation of this residue accomplishes the same task as Ca2+/CaM binding by
exposing the catalytic site. P-Thr287 CaMK-II remains 20-80% active, generating what is known
as Ca2+/CaM-autonomous activity. Only upon dephosphorylation of this residue will CaMK-II
become inactive and the conformation shift back to the closed configuration (Rosenberg et al.,
2005).
8Alternative splicing within the variable domain generates subcellular-targeted CaMK-II
that allows for varied access to substrates. Domains II and VII are considered the “linker”
domains between the catalytic and association domains and are present in all CaMK-IIs. Domain
I increases the binding affinity for CaM, thus creating a more sensitive enzyme as well as
influencing the ability of the enzyme to autophosphorylate (Bayer et al., 2002; Brocke et al.,
1999). An alternative promoter within domain II of α CaMK-II generates αKAP, a catalytically
inactive CaMK-II. A hydrophobic leader sequence targets catalytically active CaMK-IIs to
membranes (Bayer et al., 1998). Domain III encodes a nuclear targeting sequence and
preferentially targets the holoenzyme to the nucleus (Srinivasan et al., 1994; Tombes et al.,
2003). The functions for the proline-rich exons IV and V are unknown at present, however it is
noteworthy that the two exons are usually found together and not alone. Domain VI functions to
antagonize the nuclear localization sequence, domain III, in γ CaMK-II. Domain VIII/IX can be
encoded by a single exon, similar to domain IV/V, and is also proline rich. Domain X codes for
SH3 binding domains, targeting the holoenzyme to membranes (Tombes et al., 2003).
Originally identified as a neuronal specific protein, CaMK-II has now been found in
virtually every tissue type in mammals, phosphorylating a number of substrates to influence a
variety of cellular mechanisms (Tombes et al., 2003). CaMK-II phosphorylates AMPA receptors
in the brain generating long-term potentiation. Homozygous mice lacking neural specific α
CaMK-II fail to develop long-term potentiation (Silva et al., 1992). Other neuronal substrates
include proteins important at the postsynaptic density such as SHANK, SynGAP, and spinophilin
(Dosemeci and Jaffe, ; Oh et al., 2004). Fewer nonneuronal substrates of CaMK-II are known. In
the heart CaMK-II phosphorylates ryanodine receptors to release Ca2+ stores for the ER and
phosphorylates phospholamban to promote the reuptake of Ca2+ into the ER by the sarco-
9endoplasmic reticulum Ca2+ ATPase (SERCA) (Maier and Bers, 2002). Hypertrophy and heart
failure have been linked to alterations in CaMK-II activity. Other nonneuronal substrates include
caldesmon, CREB, EGFR, Vimentin, and HDAC4 (Feinmesser et al., 1999; Little et al., 2007;
Stefanovic et al., 2005; Wang and Yang, 2000; Wu and McMurray, 2001).
CaMK-II has also been implicated in many cellular mechanisms, however identifying
substrates has remained a challenge (Bayer and Schulman, 2001; Soderling, 2000). The Tombes
lab has linked CaMK-II to cell-cycle progression, cell motility, neurite outgrowth, heart
morphogenesis, and establishment of left-right asymmetry (Easley et al., 2006; Easley et al.,
2008; Faison et al., 2002; Francescatto et al., 2010; Morris et al., 1998; Rothschild et al., 2009;
Seward et al., 2008; Tombes et al., 1995). Other functions of CaMK-II include ion channel
regulation, transcription, and secretion (Hudmon and Schulman, 2002a; Hudmon and Schulman,
2002b; Schulman et al., 1992).
Suppressing CaMK-II expression in well-established model systems will increase our
understanding of most Ca2+-dependent cellular pathways that lead to developmental disorders
and adult syndromes in humans.  Mouse CaMK-II knockouts are embryonic lethal and therefore
cannot be used to study later CaMK-II functions in vivo. Zebrafish are an ideal vertebrate
organism to study CaMK-II function given the many knockdown techniques, external
fertilization, and transparent embryos. The purpose of this dissertation has been to identify all
CaMK-II genes in zebrafish and then characterize their roles during zebrafish development.
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Chapter 2: Differential Expression of CaMK-II Genes During Early Zebrafish
          Embryogenesis
ABSTRACT
CaMK-II is a highly conserved Ca2+/calmodulin-dependent protein kinase expressed throughout
the lifespan of all vertebrates. During early development, CaMK-II regulates cell cycle
progression and “non-canonical” Wnt-dependent convergent extension. In the zebrafish, Danio
rerio, CaMK-II activity rises within 2 hr after fertilization. At the time of somite formation,
zygotic expression from six genes (camk2a1, camk2b1, camk2b2, camk2g1, camk2g2, camk2d1,
camk2d2) results in a second phase of increased activity. Zebrafish CaMK-II genes are 92-95%
identical to each other and to their human counterparts in the non-variable regions. During the
first three days of development, alternative splicing in the variable region yields at least 26 splice
variants, many of which are unique. Whole-mount in situ hybridization reveals that camk2g1 and
camk2b2 comprise the majority of maternal expression. All seven genes are expressed strongly
in ventral regions at the 18-somite stage. Later, camk2a1KAP is expressed in anterior somites
and heart, while camk2a1 is expressed primarily in the forebrain. Camk2b1 is expressed in
somites, mid- and forebrain, gut, retina, and pectoral fins. Camk2b2 expression is high in the
brain and pectoral fins and transiently expressed in the heart at 36hpf. Camk2g1 appears strongly
along the midline and then in brain, gut, and pectoral fins. Camk2g2 is expressed early in the
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midbrain and trunk and exhibits the earliest retinal expression. Camk2d1 is elevated early at
somite boundaries, then epidermal tissue, while camk2d2 is expressed in discrete anterior
locations, steadily increasing along either side of the dorsal midline and then throughout the
brain, including the retina. Suppression of each gene using antisense morpholino
oligonucleotides reflects the aforementioned mRNA expression pattern, yielding defects in
somite, eye, fin, heart and anterior-posterior axis development. These findings reveal a complex
pattern of CaMK-II gene expression consistent with pleiotropic roles during development.
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INTRODUCTION
Although Ca2+/calmodulin-dependent protein kinase type II (CaMK-II) is best known for
its role in the central nervous system, CaMK-II has now been identified in every tissue
throughout the life cycle. Interestingly, CaMK-II comprises 1% of all protein in the hippocampus
in mice, demonstrating the importance of this protein in synaptic plasticity and long-term
potentiation (Burgin et al., 1990; Mayford et al., 1996).  However, CaMK-II is also important in
gametogenesis, and at fertilization where it promotes meiotic resumption in frog and mouse
oocytes (Johnson et al., 1998; Lorca et al., 1993; Winston and Maro, 1995). During
development, CaMK-II is activated by members of the “non-canonical” Wnt family of
glycoproteins, such as Wnt5, to promote cell movement during gastrulation (Kuhl et al., 2001;
Sheldahl et al., 2003).
CaMK-II variability is primarily achieved through alternative exon usage in the central
variable domain, yielding over 40 splice variants from the four CaMK-II genes (Hudmon and
Schulman, 2002b; Tombes et al., 2003). Some of these variants are specifically targeted to the
nucleus, the plasma membrane, the actin cytoskeleton, and post-synaptic densities (Caran et al.,
2001; Heist and Schulman, 1998; Shen and Meyer, 1999; Srinivasan et al., 1994; Takeuchi et al.,
2000; Urquidi and Ashcroft, 1995). Differential expression of CaMK-II genes occurs throughout
the adult vertebrate body (Tobimatsu and Fujisawa, 1989), during embryogenesis, and are most
commonly expressed in the developing central nervous system (Bayer et al., 1999) and in the
developing cardiac system (Baltas et al., 1995; Edman and Schulman, 1994; Hagemann et al.,
2001; Hoch et al., 2000; Singer et al., 1997). β CaMK-II is required for mouse embryonic
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development (Karls et al., 1992), but α CaMK-II is not expressed until after birth (Brocke et al.,
1995).
CaMK-II is unique from other CaM-dependent proteins because it is able to distinguish
Ca2+ signals by frequency and amplitude through oligomerization and autophosphorylation,
allowing the enzyme to remain active in the absence of Ca2+/CaM (Tombes et al., 2003). In
addition all subunits do not need to be activated by CaM for the enzyme to phosphorylate
substrates and influence cellular mechanisms. These properties, along with subcellular targeting,
identify CaMK-II as a key protein in translating Ca2+ stimuli into diverse cellular responses.
Although many studies have identified functions for CaMK-II, developmental studies
have been challenging since many CaMK-II mouse knockouts are embryonic lethal. Zebrafish
are a valuable system to study in vivo protein suppression due to their external fertilization, rapid
development, and the varied knockdown methods for suppressing the expression of specific
genes.  In fact, zebrafish rely on diffusion for oxygen during the first five days of development,
allowing the embryo to remain alive in the absence of blood flow (Yelon, 2001 ). This makes
zebrafish an attractive model system to study the developmental role of CaMK-II in vivo.
Although, δ CaMK-II had been identified in a previous study (Strausberg et al., 2002), a
total of seven zebrafish CaMK-II genes and eight open reading frames (ORFs) have now been
identified in this project as transcriptionaly active during the first 3 days of development. KN-93,
a calmodulin binding antagonist (Tombes et al., 1995), was used to suppress zebrafish CaMK-II
activity and determine potential functions of CaMK-II. In addition, translation blocking antisense
morpholino oligonucleotides were designed against the eight ORFs to determine the requirement
for each during development. Each MO caused unique defects that demonstrate the requirement
for CaMK-II in axis patterning, organogenesis, and left-right patterning. These are the first
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studies to comprehensively evaluate all CaMK-IIs during development and demonstrate the
importance of this signaling molecule in the development of vertebrate embryos. The findings in
this chapter set the stage for all subsequent studies.
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MATERIALS AND METHODS
Zebrafish care and maintenance
Wild type fish were obtained from the Zebrafish International Resource Center and
maintained at 28.5ºC. Embryos were obtained through natural crosses, raised at 28.5ºC and
staged as previously described (Kimmel et al., 1995).
Whole cell lysate preparation
Embryos were dechorionated and then lysed in 30 mM HEPES, pH 7.4, 20 mM MgCl2,
80 mM β-glycerol phosphate, 5 mM EGTA, 0.1 µM okadaic acid (Life Technologies Invitrogen,
Carlsbad, CA), 0.01 mg/ml each chymostatin, leupeptin, aprotinin, pepstatin, and soybean
trypsin inhibitor (Sigma Chemical Co.), sonicated for 5 sec on ice, and centrifuged at 12,000xg
for 15min at 4ºC. This buffer has been optimized for maximal recovery into this supernatant
(Tombes et al., 1999; Tombes and Peppers, 1995). Protein concentrations were determined using
the BCA assay (Pierce Chemicals).
CaMK-II activity assay
Total CaMK-II activity was assessed by measuring phosphate incorporation into
autocamtide-2, a peptide modeled after the autophosphorylation site of CaMK-II
(KKALRRQETVDAL). Reactions were carried out on 1-2µg protein from cell lysates in a total
volume of 25µl containing final concentrations of 20 mM HEPES (pH 7.4), 0.1 mM
dithiothreitol, 15 mM magnesium acetate, 20 mM β-glycerophosphate, 10 mM NaF, 0.5 µM
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PKA inhibitor peptide, 0.1 µM okadaic acid, 10 µM [γ-32P]-ATP (0.5 mCi per assay), 35 µM
autocamtide-2, and either 1 mM EGTA (-Ca2+) or 1 µM bovine calmodulin plus 2.0 mM CaCl2
(+Ca2+). After 10 min at 32ºC, 20 µl was pipetted onto P81 phosphocellulose paper squares
(Whatman) that were air dried for 1 min and washed five times in 500 ml 1% phosphoric acid.
Dried paper squares were quantitated by Cerenkhov counting in the absence of scintillation fluid.
These assay conditions were optimized for compatibility with the buffer in which cell lysates
were prepared (Tombes et al., 1999; Tombes and Peppers, 1995). Activity detected by AIP, the
autoinhibitory peptide (Biomol) whose sequence is KKALRRQEAVDAL, was measured. Using
partially purified CaMK-II from 6-day zebrafish embryos, we determined that this peptide could
half maximally inhibit at 10 µM and was 90% effective at 25 µM, which are values very similar
to that seen with partially purified mouse CaMK-II (Tombes and Peppers, 1995).
Genomic identification
Sequences were obtained by searching GenBank and Sanger Institute genomic databases
using a BLAST (Basic Local Align Search Tool) search for zebrafish CaMK-II homologs. Seven
CaMK-II genes were identified and are listed with accession number and GenInfo sequnce
identification numbers (gi). They include camk2a1 (chromosome 21, NM_001017741, g1:
82524730); camk2b1 (chromosome 5, XM_685461, gi: 68437880); camk2b2 (chromosome 10,
NM_, camk2g1 (chromosome 12, BC096785, gi: 66911241); camk2g2 (chromosome 13,
XM_689010, gi: 68437880); camk2d1 (chromosome 7, BC077143, gi: 50417146) and camk2d2
(chromosome 1, NM_001002542, gi: 50540149).
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RT-PCR and sequencing
Total RNA was prepared from dechorionated embryos at 1hpf, 24hpf, and 72hpf and
cDNA was prepared as described (Lister et al., 2001). PCR primers, which bracketed the variable
region, include three sense primers (TGGATCTGCCAACGCTCCACTGTGGC,
TGGATATCACATCGCTCCACCGTCGC, TGGAGTCATCCTCTACATCCTGCTGG), which
encode WICQRSTVA, WISHRSTV, and GVILVILL respectively, and three antisense primers
(CCTCATGTGCACCTGATTGGAGA, CACAGTTTGTGGATGGCCAGGGCC,
GTACCGAGCAGCTGATTGAAGCC), which encode PHVHLIGE, QFVDGQG, and
VTEQLIEA. These primers were used in various combinations in order to achieve the greatest
coverage of all potential CaMK-II sequences. CaMK-II PCR products were cloned into the
TOPO/TA vector (Invitrogen) and clones were screened by PCR, purified, and then sequenced.
Over 100 clones were screened in this fashion.
Whole mount in situ hybridization
Digoxigenin-labeled anti-sense riboprobes (0.5-1.5kb) were synthesized using T3 or T7
RNA polymerase (orientation dependent) from TOPO/TA vector-based cDNAs and then
incubated with fixed, staged embryos as described (Dutton et al., 2001). Individual probes
derived from cDNAs encoding the splice variants, αKAP, β1e, β2G, γ1G, γ2L, δ1G, and δ2E were
used to localize all transcripts from each gene. The αKAP probe was synthesized from a
purchased clone (Open Biosystems) whereas other probes were synthesized from TOPO/TA
clones. Anti-digoxigenin and alkaline phosphatase conjugated secondary antibodies were used
and developed with NBT/BCIP as substrate. Sense probes showed no signal. In some cases,
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stained embryos were embedded in NEG-50 frozen sectioning medium (Richard-Allan
Scientific), frozen to -20ºC and 30µm sections obtained using an HM-550 cryostat (Richard-
Allan Scientific). Sections were rehydrated in 50% glycerol and photographed with a Nikon
Cool-Pix 990 color camera on an Olympus IX-70 phase contrast microscope. Whole-mount
specimens were photographed with an Olympus DP70 digital camera on an Olympus SZX12
stereo microscope.
Immunolocalization
Wild-type and KN-93 treated embryos were fixed in 4% PFA for four hours at room
temperature and then washed several times with 1XPBT. Embryos were blocked in 10% goat
serum in 1x PBT for one hour at room temperature and then incubated in a 1:1000 dilution of
mouse anti-acetylated alpha tubulin (Sigma) overnight at room temperature in block. Embryos
were incubated with goat-anti-mouse Alexa-568 (Molecular Probes) for four hours at room
temperature and imaged on a LSM 510 laser scanning confocal microscope (Zeiss) .
KN-93 Treatment
20-30 embryos were incubated continuously in 10 µM KN-93 in 3mls of system water
from cleavage stages in 6 well dishes.
Morpholino Oligonucleotide Injections
Morpholino antisense oligonucleotides (MO’s) were designed to disrupt translation by
complementary base pairing to the predicted or known translational start sites of full length
zebrafish or mammalian CaMK-II cDNAs. MO’s were purchased from Gene Tools (Philomath
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OR) and are shown for each gene in the 5’-3’ direction with the sequence corresponding to the
start codon underlined and mRNA nucleotide positions indicated.
camk2a1: GCCATCCTGGAAGCGTGTGCGCCTC-3’; nts -20 to +5,
camk2a1KAP: GGCATAGCGGTGGTCTGCTCTCCAC; nts -20 to +5,
camk2b1: GGCCATGTCTTCCCGTCTCGGACTC; nts -19 to +6,
camk2b2: GCGTGCAGGTTGTGGTTGCCATGTC; nts -3 to +19),
camk2g1: AATTGTAGCCATGTTGTGTGTGCGT; nts -13 to +12),
camk2g2: AATTGTAGCCATGTTGCGCTTTACG; nts -13 to +12),
camk2d1: CAGGTTGTTGAAGCCATGCTGAAAG; nts -8 to +17),
camk2d2: CAGATGGTCAGAGCCATTGTGATG; nts -7 to +17).
Mismatch: CAATGCTCACAGCGATTGTCATG
Morpholino stocks (1mM) were stored in aliquots at -80°C. Prior to injection, aliquots were
heated to 65°C for 5 min, cooled to room temperature and then diluted in Danieau buffer
(Westerfield, 1993). The dose-dependent effectiveness of each MO at suppressing CaMK-II
expression was assessed by CaMK-II peptide assay, as described (Rothschild et al., 2007).
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RESULTS
CaMK-II Activity Increases in Two Phases During Early Development
CaMK-II activity can be measured using a well-established CaMK-II specific assay,
where the incorporation of radioactive 32P into a synthetic peptide, autocamtide-2, is measured.
The autocamtide-2 peptide is modeled after the autophosphorylation site of CaMK-II,
KKALRRQETVDAL. Whole embryo lysates were prepared from various time points during the
first three days of zebrafish development and a biphasic activity pattern was identified. At all
stages, activity was Ca2+/calmodulin dependent and could be inhibited by 20 µM AIP, a peptide
that mimics the autoinhibitory domain found in all CaMK-IIs and that has previously been used
to inhibit sea urchin CaMK-II (Baitinger et al., 1990). No activity was detected at the 1 cell
stage, which was surprising given the evidence for CaMK-II in early meiotic events in other
model systems. Activity began increasing immediately after the 1-2 cell stage coincident with
known Ca2+ elevations in the early embryo (Jaffe, 1995). CaMK-II activity levels remained
stable from 4-12hpf, but then increased again at 24hpf, about five-fold (Figure 2.1). At 24hpf the
zebrafish embryo heart begins beating, the notochord vacuoles inflate, and the embryo is able to
respond to touch stimulus, demonstrating the increase in complexity of the embryo and the need
for greater concentrations of the multifunctional CaMK-II. At 3dpf total CaMK-II activity
continues to increase, approximately 100-fold compared to the 1-cell embryo, and continues
rising until 6dpf where activity levels off. At 6dpf the zebrafish is in the larval stage of
development and can free swim, feed, and respond to external stimuli. The specific activity of 6-
day embryos is comparable with that found in mouse embryonic cells (Tombes et al., 1995).
21
Identification of Zebrafish CaMK-II Genes
The identification of zebrafish CaMK-II genes was determined using best fit BLAST
searches using known mammalian sequences (Tombes et al., 2003). There are four known
CaMK-II genes in mammals and birds, and a single gene in Drosophila and C. elegans, however
due to a genome wide duplication event in the teleost lineage (Postlethwait et al., 2004) there are
seven catalytically active CaMK-II genes and one catalytically inactive, membrane targeting
gene. The seven genes are shown with their predicted and aligned protein sequences (Figure 2.2).
Alternative sequences from the variable domain are omitted from this alignment as previously
described (Tombes et al., 2003). Based on gene-specific residues and sequence similarity we
concluded that there is one α gene (camk2a1), two β genes (camk2b1 and camk2b2), two γ genes
(camk2g1 and camk2g2), and two δ genes (camk2d1 and camk2d2). An alternative promoter
within camk2a1 generates αKAP, a catalytically inactive CaMK-II that oligomerizes with active
CaMK-II to target the holoenzyme to the membrane via a hydrophobic N-terminal sequence
(Bayer et al., 1998). Pairwise identity of amino acid sequences within all seven genes ranged
from 80-96% and from 90-96% when compared to the corresponding human CaMK-II.
Identification of CaMK-II Splice Variants in Zebrafish
The presence of alternative splice variants in each CaMK-II gene was evaluated using
RT-PCR (Tombes and Krystal, 1997). Redundant and gene-specific primers that flank the
variable region were used to amplify oligo dT-primed or random hexamer-primed cDNA
synthesized from RNA isolated from zebrafish embryos between 1 and 72hpf. PCR products
were cloned and screened by sequence.
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All eight CaMK-II ORFs expressed at least one mRNA during the first three days of
development demonstrating their transcriptional activity. Twenty-six different splice variants
from these seven genes were identified (Figure 2.3a). According to zebrafish genome
conventions and those previously established for this gene family, each splice variant is
identified by a Greek letter and number referring to the paralog followed by a letter subscript.
The predicted amino acid sequence of each of these variants predicts alternative exon usage as
previously described for human sequences (Tombes et al., 2003). All CaMK-II genes contain
linker domains II and VII within the variable region and may encode for alternative domains I,
III, IV, V, VI and VIII/IX.
Between one and eight variants were found from each gene. Eleven of the twenty-six
variants are novel. Six variants contain domain I, which is thought to influence CaM binding
affinity (Bayer et al., 2002; Brocke et al., 1999). Six of the variants contain domain III, a putative
nuclear targeting domain. The functions of domains IV and V are not known while domain VI is
thought to interfere with nuclear localization in γ CaMK-II. Four variants contain domain
VIII/IX, which may influence cell-surface binding. The twenty-six variants fall into 13
categories of alternative exon utilization (Figure 2.3b). Category 4 encodes domains II, VI, VII
and was the most common combination with 4 variants represented. We identified several
maternal transcripts including α, β1K, γ1C, γ2L, γ2O, and γ2P. γ1C had the highest contribution of
maternal CaMK-II. Interestingly even though several CaMK-II splice variants are present as
mRNA in the early cleavage embryo, it appears that the corresponding proteins may not be
translated, as indicated by low embryonic activity. The predicted full-length, molecular weight of
all 26 CaMK-II variants is between 54 and 60 kDa.
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Embryonic Localization of CaMK-IIs During Early Development
In situ hybridizations were performed to identify the timing and tissue localization for
each of the seven genes. Zebrafish embryos were fixed and stained at various developmental
stages up to 3dpf. Expression at the 8-cell (1hpf) and 512-cell stage (2.5hpf) reflects maternal
mRNA expression since zygotic expression does not commence until after the mid-blastula
transition, which occurs at approximately high stage (3.5hpf). Somite stage embryos were
evaluated at the 3-somite (11hpf) and 18-somite stage (18hpf). Each gene revealed unique spatial
and temporal expression as summarized in Table 2.1. The majority of the CaMK-II expression
occurred once zygotic expression commenced, as demonstrated by the activity assays (Figure
2.1).
α1 (camk2a1) transcripts are expressed maternally and then appear to be expressed in lower
levels diffusely through the early embryo but  then absent at dome and shield stages. At the 3-
somite and 18-somite stages camk2a1 is expressed ubiquitously until 48hpf where expression is
confined to the forebrain region, heart, and somites. Heart and somite expression has been
identified as α1KAP and not catalytically active camk2a1 through RT-PCR and a camk2a1
specific antisense riboprobe. At 72hpf camk2a1 expression remains in the forebrain region and
α1KAP expression persists in the heart and somites (Figure 2.4). Only one camk2a1 and one
a1KAP splice variant were cloned and both encode for the simplest splice variant, containing
exons II and VII.
β1 (camk2b1) mRNA was detected maternally at the 8-cell and 512-cell stage and then
persisted at low levels through the 3-somite stage. At 18 somites, the expression increases and is
identifiable in ventral regions of the embryo and brain. Expression persists ventrally and in the
somites at 24hpf and becomes more discrete in the brain and heart at 48hpf. By 72hpf,
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expression was strong in mid- and forebrain regions and lightly in the gut, retina, trunk, and
pectoral fins (Figure 2.5). Two of the three β1 splice variants contain a putative nuclear targeting
sequence. Further analysis of manually dissected hearts at 48hpf identified the β1K variant as the
predominant heart CaMK-II.
β2 (camk2b2) mRNA was identified at high levels at the 8 and 512 cell-stage identifying
it as a maternally expressed gene. Expression persists through somitogenesis and is found in the
somites at 24hpf. At 36hpf camk2b2 mRNA is transiently expressed in the heart. Expression is
also identifiable in the brain, pectoral fins, and somites. By 72hpf expression diminishes and β2
mRNA is detected weakly in the forebrain (Figure 2.6). This gene encodes four splice variants
during the first three days of development, with one variant containing domain I.
The strongest maternal expression detected during early cleavage stages and gastrulation
was encoded by γ1 (camk2g1) (Figure 2.7). Expression at the 512-cell stage identifies camk2g1
in both the yolk syncitial layer and the entire blastocyst. At the 18-somite stage expression is
evident in the somites, brain, and kidney. By 24hpf, expression is very strong in the ventral
somites, spinal cord cell bodies, and brain. mRNA is evident in the hindbrain, fins, otic placode,
ventral organs, and somites at 48 and 72hpf. Of the four camk2g1 variants identified, one
contains a putative nuclear localization sequence, whereas one contains domain I, and one
contains the putative membrane targeting domains VIII/IX.
γ2 (camk2g2) expression was found early in cleavage stage embryos and is expressed
ubiquitously throughout the embryo until the 18-somite stage, where expression is localized
ventrally and in the brain. Expression becomes more discrete in the brain at 48hpf and 72hpf
where γ2 is found strongly in the entire brain and lightly in the retina and pectoral fins (Figure
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2.8). This gene encodes 8 splice variants during the first three days of development, which is the
greatest number of variants encoded by any of the eight ORFs, with 3 maternal variants.
δ1 (camk2d1) expression was not evident during early cleavage stage embryos and was
first visible at 18-somite stage in the somites (Figure 2.9). This result is consistent with results
from RT-PCR where no transcripts were identified during early development. At 24hpf δ1
expression appears low in the brain but much higher in the hatching gland. At 48hpf mRNA
expression decreased with light expression in the brain, which persisted through 72hpf. The two
δ1 splice variants identified were simple cytosolic variants, utilizing few alternative exons.
δ2 mRNA expression (camk2d2) was undetectable until the 18-somite stage. At 24hpf
expression is identified in the brain, specifically forebrain and hindbrain regions. This expression
persists through 72hpf where strong expression is apparent in the brain and retina (Figure 2.10).
Three non-nuclear variants were identified with one variant containing the putative membrane
targeting domains, VIII/IX.
Frozen thin sections were also used to identify CaMK-II expression in the central nervous
system of β1, γ1, γ2, and δ2 at 72hpf. Locations at cross-sections are identified (A-F) in Figures
2.4- 2.9. All four genes were expressed in the retinal epithelia with δ2 and γ1 expressed in
ganglion cell and amacrine layers. β1 and γ1 were intensely co-expressed in a cortical rim in the
midbrain, whereas δ2 was expressed in a thin intense layer in the hindbrain. In addition, γ1 was
expressed in the otic placode, while δ2 was expressed in more dorsal region of the hindbrain
(Figure 2.11).
KN-93, a CaMK-II Inhibitor, Causes Developmental Defects in Zebrafish Embryos
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KN-93, a calmodulin binding antagonist, maintains CaMK-II in the basal state, even in
the presence of CaM (Tombes et al., 1995). Treatment with KN-93 causes cell cycle arrest and
apoptosis in cell culture (Tombes et al., 1995), inhibits sperm flagellar motility in coral (Morita
et al., 2009) and ascidians (Nomura et al., 2004), and has been shown to block meiotic
progression in mouse oocytes (Madgwick et al., 2005). Treatment with an inactive analog, KN-
92, has no affect on CaMK-II activation or cell behavior (Tombes et al., 1995). Zebrafish
embryos were treated with increasing concentrations of KN-93 beginning at cleavage stages and
imaged at 3dpf (Figure 2.12a). Blood pooling, upward tail curvature, shortened pectoral fins,
reduced circulation, and failure to hatch from the chorion are evident by 3dpf. CaMK-II activity
decreases with a half-maximal inhibitory concentration of 4µM (Figure 2.12b). In addition, KN-
93 treatment caused a disorganization of axonal projections from spinal cord cell bodies as
demonstrated by confocal z-stack renderings of embryos immunolabeled with an anti-acetylated
α-tubulin antibody (Figure 2.13a,b).
Morphant Phenotypes Mirror CaMK-II mRNA Expression Patterns
Gene-specific translation blocking morpholino oligonucleotides were designed against
each of the seven catalytically active CaMK-IIs and αKAP (Table 2.2). These eight MO’s were
titrated to determine the minimum concentration required to yield a reproducible phenotype
(Figure 2.13). Morphants were imaged at 48hpf and assessed for gross morphological defects at
3dpf (Figure 2.13 and Table 2.3).
Suppression of each CaMK-II gene generated mostly unique and some overlapping
phenotypes. Camk2b2 and camk2g1 mRNAs are expressed at high levels compared to the other
CaMK-II genes prior to the MBT and throughout development. Suppression of these two genes
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caused a myriad of defects including embryonic lethality.  1.25 ng of camk2g1 morpholino
caused convergent extension defects, alteration in the establishment of left-right asymmetry,
somite compression, atrial enlargement, hydrocephaly, pericardial edema, cloacal occlusions,
pronephric cysts, and coloboma. Camk2g1  morphants did not live past 3dpf.  Camk2b2
knockdowns using 2pg of morpholino also suppressed the establishment of left-right asymmetry
and caused the development of hydrocephaly. However suppression of camk2b2 also induced
heart looping defects, bradycardia, decreased circulation, somite defects, and diminished pectoral
fin development. These defects match the expression of camk2b2 in the heart at 36hpf, when the
heart begins to undergo looping, and camk2g1 at the shield when convergence and extension
occurs. Therefore the time and location of expression of each gene is consistent with the
phenotypes.
Higher concentrations of camk2a, camk2b1, camk2g2, camk2d1, and camk2d2
morpholinos were necessary to observe knockdown phenotypes. This was not because of lower
Tm or GC content. Suppression of camk2b1 caused mild convergent extension and notochord
defects, suppression of camk2g2 caused hydrocephaly, camk2d1 and camk2d2 knockdowns only
caused mild brain necrosis. Although these CaMK-II genes are expressed throughout embryonic
development, each gene has a specific function.  Some of these functions may overlap which
could explain the lack of phenotype in camk2g2 morphants when there are so many splice
variants (8) expressed throughout the embryo.  In addition, CaMK-II is known to function in the
CNS and therefore knockdown of zebrafish CaMK-II genes may cause brain defects that cannot
be defined simply by looking at gross morphology.  The suppression of all seven catalytically
active CaMK-II genes does cause a reduction in overall CaMK-II activity.  However suppression
of camk2b2 and camk2g1 caused the largest reduction (Figure 2.14).
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DISCUSSION
In this study, CaMK-II expression was comprehensively monitored from fertilization
through early development in the zebrafish. Our findings are consistent with other studies, which
have implicated CaMK-II during events around the time of gastrulation and then in the
developing circulatory and central nervous systems. This study also raises possibilities for the
involvement of specific CaMK-IIs in the formation of the anteroposterior axis, somites, retinal
epithelia, gut, and other tissues. The numerous CaMK-II variants encoded during this time period
in a spatially and temporally regulated manner support complex transcriptional and post-
transcriptional gene regulation and imply multiple roles for members of this protein kinase
family.
Like other genes in teleost fish, CaMK-II genes have been duplicated. At least three
quarters of the duplicated CaMK-II genes have been retained and are transcriptionally active. In
contrast, only 20-30% of all duplicated zebrafish genes are retained (Postlethwait et al., 2004).
The seven CaMK-II genes encode between one (α1) and eight (γ2) splice variants. By both RT-
PCR and in situ hybridization, several of these genes are expressed maternally, including
mRNAs from the α1, β1, β2, γ1 and γ2 CaMK-II genes. Maternal CaMK-IIs are not just the
simple variants, but utilize alternative domains implicated in CaM binding or in targeting to the
nucleus or membrane.
Surprisingly, no CaMK-II enzymatic activity was detected at fertilization, in contrast to
the significant activity found in other species (Baitinger et al., 1990; Johnson et al., 1998;
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Stevens et al., 1999; Winston and Maro, 1995). This is surprising since zebrafish eggs are
fertilized at metaphase II (Becker and Hart, 1996), where CaMK-II has been implicated in
enabling the release from meiosis II arrest (Johnson et al., 1998; Lorca et al., 1993; Winston and
Maro, 1995). Within the first two hours of development, however, active CaMK-II is detected at
the time when developmentally important Ca2+ transients are known to occur (Creton, 2004;
Creton et al., 1998; Gilland et al., 1999). Activity assays and in situ localization support complex
CaMK-II expression patterns as a result of maternal mRNA and zygotic gene expression.
At least six of the seven zebrafish CaMK-II genes are expressed in the developing
nervous system, supporting the importance of this gene family in central nervous system
development (Hudmon and Schulman, 2002b). In the mouse, the CaMK-II gene is expressed
exclusively postnatally in the hippocampus and frontal cortex (Bayer et al., 1999; Burgin et al.,
1990). Only one α CaMK-II gene has been uncovered so far in the zebrafish, so it is possible that
another α  CaMK-II gene may be expressed in the adult zebrafish brain. For this reason, we have
numbered each zebrafish CaMK-II gene with a numerical postscript even though, in the case of
α1, only one paralog has so far been identified from either the searches of zebrafish genome
databases or from splice variant sequences.
Manually dissected 36 and 48hpf hearts expressed a1KAP, camk2b1 and camk2b2, with
the camk2b1 variant containing a putative nuclear localization sequence and camk2b2 a cytosolic
variant. A non-catalytic splice variant of the gene, αKAP, has been found in mammalian cardiac
muscle (Singh et al., 2005; Sugai et al., 1996), where it oligomerizes with and targets active β
CaMK-II to membranes, such as the sarcoplasmic reticulum (Sugai et al., 1996; Takeuchi and
Fujisawa, 1997). In situ locations reflect this non-catalytic variant; where it could hetero-
oligomerize with camk2b2 to influence excitation-contraction coupling.
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Multiphasic expression was most apparent with β1 and γ1 CaMK-II, as described above
and summarized in Table I. β1 was expressed within the first day in all somites, was lost along
the trunk at 48hpf, but re-appeared strongly in the brain, gut, retina, and pectoral fins at 72hpf. γ1
mRNA was prevalent in cleavage-stage embryos and then along either side of the midline at
24hpf, was significantly decreased at 48hpf, and then reappeared in brain, gut, and pectoral fins.
These patterns of expression suggest that these two CaMK-II genes are controlled by one set of
transcriptional regulatory influences at 24hpf and another set at 72hpf. The additional influences
of mechanisms that control alternative splicing during development is not known for CaMK-II
genes, but could be initially assessed by quantitative analysis of the relative levels of each splice
variant through development and/or detailed analysis of cis-regulatory elements.
Retinal expression of CaMK-II has previously been reported in the synaptic and pigment
epithelial layers (Bronstein et al., 1988), but these and other studies have primarily implicated α
CaMK-II (Laabich et al., 2000; Liu and Cooper, 1996). Our studies indicate that four CaMK-II
genes are expressed in the retina; the only CaMK-IIs not expressed in the developing retina are
encoded from the α1 and the δ1 genes. Among the retinal layers, our results indicate that each of
the four CaMK-II genes encodes its own unique pattern of retinal expression.
Zebrafish CaMK-II localization is consistent with its involvement in non-canonical Wnt
pathways (Kuhl et al., 2000a; Kuhl et al., 2000b; Sheldahl et al., 2003). Non-canonical Wnts
induce convergent extension movements during and after gastrulation (Tada et al., 2002). In
zebrafish, defects in convergent extension movements are observed with the Wnt5 pipetail
mutant (ppt) (Kilian et al., 2003) and its receptor, frizzled 2 (Sumanas et al., 2001).
Pharmacological disruption of Ca2+ dynamics during the discrete developmental window (6-
8hpf) associated with gastrulation also leads to defects in axis formation (Creton, 2004). Wnt5
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has been implicated in the specification of myoblasts (Anakwe et al., 2003) and retinal cells (Yu
et al., 2004) and activates CaMK-II (Kuhl et al., 2000a). Wnts 4, 5a, and 11 also influence the
midline assembly of organ precursors, including liver, gut, pancreas, and heart, all of which
require mesoderm migration (Kim et al., 2005; Pandur et al., 2002). The reported elevation of
CaMK-II activity on the ventral side of the embryo (Kuhl et al., 2000a) is consistent with our
observation that five of the seven zebrafish genes express ventrally at early stages of
development. In general, the co-incidence of CaMK-II expression with members of the Wnt
family supports the possibility that CaMK-II diversity reflects variations in its responsiveness to
members of the Wnt family.
Convergent extension is typically accomplished through either directed migration, cell
shape changes, or cell rearrangements (Wallingford et al., 2001; Wallingford et al., 2002). These
post-transcriptional mechanisms are likely the result of alterations in the cytoskeleton through
discrete targets. Transient Ca2+ elevations have been proposed to promote focal complex
disassembly and detachment from the extracellular matrix at the periphery of motile cells
(Conklin et al., 2005; Marks and Maxfield, 1990). CaMK-II has been implicated in cell motility
in mammalian cells (Lundberg et al., 1998; Pfleiderer et al., 2004) and CaMK-II has been
detected in extracts of isolated pseudopods by mass spectrometry (Lin et al., 2004). A role for
CaMK-II in convergent extension is, therefore, likely through its direct action on the
cytoskeleton. In support of this, of the five maternal CaMK-II transcripts detected during early
development, four are extranuclear.
Why are there so many CaMK-II splice variants expressed during embryogenesis? One
fourth of the zebrafish embryo CaMK-IIs identified in this study have nuclear targeting
sequences. Nuclear targeted CaMK-IIs are known to act directly on transcription factors, such as
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CREB (Matthews et al., 1994; Ramirez et al., 1997; Shimomura et al., 1996; Sun et al., 1996).
Other CaMK-IIs that we have identified have variable spacers, which may enable them to
respond differently to exposure to Ca2+ and CaM. Others have newly discovered domains, which
may enable them to interact with binding partners, substrates, or organelles in a manner that
supports their specific functions. This study has laid the groundwork for assessing the role of
specific CaMK-IIs in discrete developmental functions.
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Figure 2.1. Developmental kinetics of CaMK-II enzymatic activity. Ca2+-dependent CaMK-
II-specific activity was measured in whole embryo lysates using the autocamtide-2 peptide-based
assay and plotted during the first 24 hr (left) and the first 10 days (right). Values shown here
were completely dependent on Ca2+/CaM and were also sensitive to 20µM AIP, a CaMK-II
specific autoinhibitory peptide.
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Figure 2.2. Zebrafish CaMK-II genes. Seven zebrafish CaMK-II genes are shown as their
predicted amino acid sequence lacking alternative variable domains. The catalytic domain
comprises the first 315 and the oligomerization domain the last 135 amino acids. The variable
region extends from amino acids 317 to 345 and corresponds to exons encoding conserved linker
domains II and VII (Tombes et al., 2003).
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Figure 2.3. CaMK-II splice variant exon utilization. Twenty different CaMK-II variants were
identified by sequencing and are shown as their amino acid sequences in the central variable
region aligned to demonstrate alternative exon utilization (A). Variants fall into eleven categories
of exon utilization (B). Exons are named and boundaries set as previously determined (Tombes
et al., 2003). Variants are named with dashes rather than subscripts in this figure for visibility.
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Figure 2.4. In situ localization of α1 and α1KAP CaMK-II mRNAs. CaMK-II expression
was assessed by in situ hybridization with a probe for camk2a1KAP at the indicated stages.
Stages analyzed include the 8-cell stage (8; 1hpf), the 512-cell stage (512; 2.5hpf), the dome
stage (Do; 4hpf), the shield stage (Sh; 6hpf), the 3-somite stage (3s; 11hpf), and the 18-somite
stage (18s; 18hpf). The 8-cell stage is an animal poll view; others are lateral except for dorsal
views at 24, 48, and 72hpf. Arrow in 48hpf camk2a1 indicates heart. Scale bar = 1 mm.
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Figure 2.5. In situ localization of β1 CaMK-II mRNA. CaMK-II expression was assessed by
in situ hybridization with a probe for camk2b1 at the indicated stages as in Figure 1.4. Arrows in
camk2b1 at 24hpf indicate somites and at 72hpf gut. Letters locate cross-sections for Figure
2.11. Scale bar = 1 mm.
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Figure 2.6. In situ localization of β2 CaMK-II mRNA.  Camk2b2 expression was assessed by
in situ hybridization at the 8 and 512-cell, 8- and 16-somite and at indicated hours (24, 34, 36, 48
and 72) post fertilization (hpf). Anterior is to the left except for the head on view of the heart at
36 hpf. Arrow heads indicate fin buds, asterisks indicate heart, v = ventricle, a = atrium, scale bar
= 1 mm.
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Figure 2.7. In situ localization of γ1 CaMK-II mRNA. CaMK-II expression was assessed by in
situ hybridization with a probe for camk2g1 at the indicated stages as in Figure 1.4. Arrows in
camk2g1 at 24hpf indicate dorsal cell bodies and at 72hpf gut. Letters locate cross-sections for
Figure 2.11. Scale bar = 1 mm.
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Figure 2.8. In situ localization of γ2 CaMK-II mRNA. CaMK-II expression was assessed by in
situ hybridization with a probe for camk2g2 at the indicated stages as in Figure 1.4. Letters locate
cross-sections for Figure 2.11. Scale bar = 1 mm.
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Figure 2.9. In situ localization of δ1 CaMK-II mRNA. CaMK-II expression was assessed by
in situ hybridization with a probe for camk2d1 indicated stages as in Figure 1.4. The 8-cell stage
is an animal poll view; others are lateral except for dorsal views at 24, 48, and 72hpf. Arrows in
camk2d1 at 24hpf indicates hatching gland. Scale bar = 1 mm.
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Figure 2.10. In situ localization of δ2 CaMK-II mRNA. CaMK-II expression was assessed by
in situ hybridization with a probe for camk2d1 and camk2d2 at the indicated stages as in Figure
1.4. The 8-cell stage is an animal poll view; others are lateral except for dorsal views at 24, 48,
and 72hpf. Letters locate cross-sections for Figure 2.11. Scale bar = 1 mm.
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Figure 2.11. Cross-sectional localization of CaMK-II mRNAs. CaMK-II expression was
localized at 72hpf by 30µm frozen thin sections of pre-stained embryos. Sections shown were
acquired at the locations (A-F) indicated in Figures 2.5, 2.6, 2.8, and 2.10 along the anterior-
posterior axis. Scale bar = 0.1 mm.
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Table 2.1. Relative levels of expression of CaMK-II genes. Temporal and spatial locations of
each gene were assessed and are summarized for all 7 genes during the first 3 days of zebrafish
development.
camk2a1 camk2b1 camk2b2 camk2g1 camk2g2 camk2d1 camk2d2
8-cell + + +++ +++ + - -
512-cell + + ++ ++ + - -
Dome - + + + + - -
Shield - + + + + - -
3-somites + + ++ + + - -
18-somites ++ + ++ ++ + + -
24hpf trunk + ++ +++ +++ + - +
24hpf Epidermis - - - - - + -
24hpf Brain - + + ++ + - +
24hpf Hatching
Gland
- + - - - + -
48hpf Heart ++ ++ ++ - - - -
48hpf Forebrain + + ++ - ++ - ++
48hpf Midbrain - + ++ + +++ - ++
48hpf Retinal
epithelia
- - - - ++ - -
72hpf Retinal
epithelia
- ++ - + + - ++
72hpf Forebrain + ++++ + ++ + - +++
72hpf Midbrain - ++++ - +++ ++ - ++
72hpf Hindbrain - ++ - ++ ++ - +++
72hpf Pectoral
fin
- + - + - - -
72hpf Gut - + - ++ - - -
72hpf Trunk - + - - - + -
Otic Vesicle - - - +++ ++ - -
Kidney - - - +++ - - -
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Figure 2.12. CaMK-II Inhibition by KN-93 Causes Developmental Defects. A. Embryos
treated with increasing concentrations of KN-93 or the inactive analog KN-62 imaged at 3dpf. B.
CaMK-II activity decreases in both 3 dpf purified zebrafish CaMK-II and 3dpf whole embryo
lysates with increasing concentrations of KN-93.
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Figure 2.12. KN-93 Treatment Inhibits Proper CNS development. KN-93 treated embryos
were assessed at 24hpf for proper spinal cord axonal development using an acetylated tubulin
antibody. (a) Control embryos have several cell bodies that project axons towards the ventral
axis of the embryo while (b) 10 µM KN-93 treated embryos have reduced axonal projections.
Scale bar = 10 µm
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Figure 2.13. CaMK-II Morphant Phenotypes at 48hpf. Translation blocking antisense
morpholino oligonucleotides designed against each gene were injected at the 1-4 cell stage and
imaged at 48hpf.  5ng of control, α1, β1, γ2, δ1, and δ2 and 1.5ng of β2 and γ1 were injected at a
constant volume of ~1nl. Scale bar = 1mm
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Table 2.2. Morpholino Sequence Data. Morpholino sequences were aligned against all CaMK-
II genes to identify possible cross-reactivity.  Target gene is first column and MO is first row.
Region of MO targeting is shown below for all CaMK-II genes with bold letters equating to
designed translation blocking MO.  All MO’s are 25 bps but δ2 is 24 bps.
Camk2a1    AAGAGGCGCACACGCTTCCAGGATGGCAACCATCACCTGCACACGCT
Camk2a1KAP AAGTGGAGAGCAGACCACCGCTATGCCCCTCACTATGCTTTCTGGGC
Camk2b1    TCCGAGTCCGAGACGGGAAGACATGGCCACGACTACATGTACGCGCT
Camk2b2    TCACAGCTGGAAGAGGACAGACATGGCAACCACAACCTGCACGCCGC
Camk2g1    CCTCCCCGCACGCACACACAACATGGCTACAATTGTAACCTCGACCA
Camk2g2    CGAAATCCTCGTAAAGCGCAACATGGCTACAATTGTAACCTGCACCA
Camk2d1    ATTGTTCTTCCTCACTTTCAGCATGGCTTCAACAACCTGCACCTGCA
Camk2d2    GCGCTGCCGATTCCCCATCACAATGGCTCTGACCATCTGCACCAGAT
Target/MO α1A(β2) α1B β1 β2 γ1 γ2 δ1 δ2 α1
KAP
α1 0 0 22 6 10 14 7 11 12
β1 8 20 0 5 12 12 12 13 17
β2 3 13 10 0 14 13 10 12 13
γ1 11 11 15 11 0 7 12 14 16
γ2 12 16 14 14 7 0 15 14 19
δ1 7 11 18 7 9 10 0 9 17
δ2 8 12 16 10 13 15 10 0 14
α1KAP 16 16 17 14 15 16 16 10 0
Cross-reacts w/ β2 - - - - - - -
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Table 2.3. Summary of CaMK-II morphant phenotypes. CaMK-II morphants were assessed
at 72hpf for morphological defects.  All morpholinos were injected with 5ng of morpholino,
accept camk2g1 at 1.25ng, camk2b2 and a1KAP at 2ng.
Gene Morphant Phenotype
camk2a1 brain necrosis, hydrocephaly
camk2b1 hydrocephaly, notochord defects, convergent extension
defects
camk2b2
hydrocephaly, bradycardia, heart morphogenesis
defects, somite defects, reduced circulation, left-right
asymmetry defects
camk2g1
hydrocephaly, heart morphogenesis defects, somite
compression, convergent extension defects, coloboma,
pronephric cysts, cloacal obstruction, left-right
asymmetry defects,
camk2g2 hydrocephaly, brain necrosis
camk2d1 brain necrosis, failure hatch from chorion
camk2d2 brain necrosis
camk2aKap left-right asymmetry defects, somite compression,
bradycardia
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Figure 2.14. CaMK-II activity in 72hpf morphant embryos. Ca2+-dependent CaMK-II-
specific activity was measured using the autocamtide-2 peptide-based assay on 72hpf whole
embryo lysates after injection of 1, 1.5, or 2ng of translation blocking MO for each gene.
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Chapter 3: Tbx-5-Mediated Expression of CaMK-II is Necessary for Zebrafish Cardiac
and Pectoral Fin Morphogenesis.
ABSTRACT
β2 CaMK-II was the first gene evaluated due to its distinctive suppression phenotype. This
phenotype is reminiscent of that association with mutations in the T-box transcription factor,
TBX5, that result in Holt–Oram syndrome (HOS), a human condition in which cardiac
development is defective and forelimbs are stunted. Morphants of _2 CaMK-II (camk2b2), but
not the _1 CaMK-II (camk2b1) paralog, exhibit bradycardia, elongated hearts and diminished
pectoral fin development. Similarly, zebrafish tbx5 morphants and mutants (heartstrings; hst)
lack pectoral fins and exhibit a persistently elongated heart that does not undergo chamber
looping. Tbx5 is expressed in the developing atrium, ventricle and in pectoral fin fields, but its
genetic targets are still being uncovered. In this study, evidence is provided that Tbx5 induces
the expression of a specific member of the CaMK-II family; this CaMK-II is necessary for
proper heart and fin development. Normal cardiac phenotypes can be restored by ectopic
expression of a human cytosolic CaMK-II in tbx5 morphants. Like tbx5, camk2b2 is expressed in
the pectoral fin and looping heart, but this expression is diminished in both tbx5 morphant and
hst embryos. Conversely, the introduction of excess Tbx5 into zebrafish embryos and mouse
fibroblasts doubles CaMK-II expression. We conclude that _ CaMK-II expression and activity
are necessary for proper cardiac and limb morphogenesis. These findings not only identify a
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morphogenic target for Ca2+ during heart development, but imply roles for CaMK-II in adult
heart remodeling.
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INTRODUCTION
Holt-Oram Syndrome
Holt-Oram syndrome (HOS) is a human autosomal-dominant disorder that affects 1 in
100,000 individuals and results in heart and limb abnormalities. This defect was mapped to the
gene encoding the T-box transcription factor, TBX5, where haploinsufficiency causes
foreshortened arms, sinus bradycardia, and septation defects (Basson et al., 1997; Basson et al.,
1994). There are over 60 germline mutations in HOS patients, including nonsense, frameshift,
and splice site mutations (Bohm et al., 2008). Many of these mutations result in a truncation that
leads to a nonfunctioning protein. Tbx5 is composed of a DNA binding domain, known as the T-
box motif, a transcriptional activator domain, and two nuclear localization signals (NLS) (Wilson
and Conlon, 2002). Tbx5 is expressed in the heart and limb during embryonic development and
becomes limited to the heart, liver, lung, prostate, and trachea of adults.  Animal models of HOS
mimic the developmental defects seen in patients and have allowed the identification of
downstream transcriptional targets (Bruneau et al., 2001; Garrity et al., 2002; Rallis et al., 2003).
In zebrafish, Tbx5 is required for heart and pectoral fin development and is expressed in
the pectoral fin bud, atrium and ventricle (Ahn Dae-gwon, 2002; Garrity et al., 2002). Tbx5
mutants (heartstrings; hst) and morphants fail to develop pectoral fins and exhibit cardiac
elongation, diminished chamber development, and bradycardia (Garrity et al., 2002). Hst mutants
fail to undergo the morphogenic process known as heart “looping,” where the atrium and
ventricle balloon and bend relative to each other (Yelon, 2001 ) Tbx5 expression is required for
early heart development and is known to induce the expression of a wide variety of genes
implicated in heart and limb development, including fgf10, sall4 and bmp6 (Harvey and Logan,
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2006; Horb and Thomsen, 1999; Ng et al., 2002; Plageman and Yutzey, 2006; Rallis et al.,
2003). It is also believed that Tbx5 acts in combination with other transcription factors, such as
Gata4, Nkx2.5 and Tbx20 to influence the expression of downstream targets, including
myocardial-specific genes amhc, cmlc2 and vmhc (Lu et al., 2008; Naiche et al., 2005).
Ca2+ and Heart Morphogenesis
Ca2+ signals have also been implicated in the morphogenesis of the heart, as Ca2+ channel
blockers, Ca2+ chelators, disruption of either Na+/Ca2+ exchanger (NCX) or SERCA2, the
sarcoplasmic reticulum (SR) Ca2+ ATPase, all interfere with cardiac looping. While T-box
family members have been shown to influence vertebrate development through Wnts and FGFs,
none of the known downstream targets of Tbx5 can explain this Ca2+ dependence.
A known target of embryonic Ca2+ signals is CaMK-II, an evolutionarily conserved
serine/threonine protein kinase. During early development, CaMK-II is activated by Wnt family
members and can rescue mutant phenotypes of certain non-canonical Wnts, whose role is to
promote cell-movements during gastrulation (Kohn and Moon, 2005). Although non-canonical
Wnts, Wnt11 and Wnt11-R, have been implicated in cardiac specification and/or morphogenesis,
a role for CaMK-II in embryonic heart development has never been defined (Eisenberg and
Eisenberg, 1999; Garriock et al., 2005; Pandur et al., 2002). CaMK-II has been implicated in
adult cardiovascular disease and heart failure and has been proposed as a therapeutic target to
minimize remodeling, arrhythmias and hypertrophy (Grueter et al., 2007; Yang et al., 2006;
Zhang et al., 2005). Substrates or binding partners of CaMK-II known to influence cardiac
function include phospholamban, L-type Ca2+ channels, and ryanodine receptors (Baltas et al.,
1995; Grueter et al., 2006; Hudmon et al., 2005; Lee et al., 2006; Zalk et al., 2007). These
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function to influence the level of intracellular calcium. An additional CaMK-II substrate is
HDAC4, a member of the Class II histone deacetylases (Little et al., 2007). Phosphorylation of
HDAC4 by CaMK-II causes HDAC4 to be shuttled out of the nucleus and remain in the cytosol
(Backs et al., 2006). This causes the upregulation of hypertrophic heart markers, such as MEF2,
which ultimately leads to cardiac hypertrophy (Zhang et al., 2003).
This study directly characterizes the function(s) of one of the seven CaMK-II genes
expressed in zebrafish. These findings support a role for β2 CaMK-II in zebrafish heart and
pectoral fin development downstream of Tbx5 and provide an explanation for the known Ca2+-
dependence of cardiac morphogenesis in a wide variety of species.
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MATERIALS AND METHODS
Zebrafish strains and care
Wild type fish embryos (AB and WIK Strains) were obtained through natural matings,
raised at 28.5°C, and staged as described (Kimmel et al., 1995). Heartstrings embryos were
obtained through natural crosses of heterozygous hst parents. The Tg(cmlc2:DsRed2) line was
generated by Tol2-mediated transgenesis. Briefly, 25 pg of a plasmid composed of Tol2
transposon ends flanking sequence from _ 210 to + 39 of the cmlc2 promoter/5_-UTR, the
DsRed2-Express open reading frame (Clontech), and the SV40 polyadenylation signal was co-
injected with 25 pg of Tol2 transposase mRNA into embryos as described.
Whole mount in situ hybridization
Digoxigenin-labeled anti-sense riboprobes (0.5–1.5 kb) were synthesized using T3 or T7
RNA polymerase from cloned cDNAs, hybridized with fixed embryos and then developed using
alkaline phosphatase-conjugated anti-digoxigenin antibodies as described above (Rothschild et
al., 2007). Dual color fluorescent in situ hybridization was conducted using digoxigenin or
fluorescein-labeled riboprobes and developed using peroxidase-conjugated anti-digoxigenin or
anti-fluorescein antibodies (Roche, Basel Switzerland) with tyramide-fluorochrome (Cy3 or
Alexa 488) derivatives (Perkin Elmer and Invitrogen) as described (Clay and Ramakrishnan,
2005). Fluorescent images were acquired using a NIKON C1 laser scanning confocal
microscope. The zebrafish cmlc2 (cardiac myosin light chain 2) probe was synthesized from
cDNA (Open Biosystems, Birmingham, ALA), which had been transferred into the TOPO/TA
vector. The tbx5 probe was prepared as described (Garrity et al., 2002). The nkx2.5, gata4 and
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bmp4 probes were obtained and prepared as described (Chen and Fishman, 1996; Kelley et al.,
1993; Martinez-Barbera et al., 1997; Peterkin et al., 2007).
Morpholino and cDNA injections
cDNAs and morpholino anti-sense oligonucleotides (MO's) were diluted in Danieau
buffer (Westerfield, 1993) and injected at the 1 to 4-cell stage. MO's directed against camk2b1
and camk2b2 were designed by Gene Tools (Philomath OR) and injected at up to 5 ng per
embryo. Two camk2b2 MO's were used (A: AGCGTGTGCAGGTGATGGTTGCCAT) and (B:
GCGTGCAGGTTGTGGTTGCCATGTC). Tbx5 (CCTGTACGATGTCTACCGTGAGGC) and
tbx4 (CCAGAACGCAGTAATTTGTCCACTT) MO's were previously described (Ahn et al.,
2002). cDNAs encoding human _C wild type (WT) CaMK-II and its constitutively active mutant
(Thr287Asp) (Caran et al., 2001) were inserted into the pFRM2.1 vector, which is under the
control of the carp _-actin promoter (Eckfeldt et al., 2005) and is therefore universally expressed.
Human _E CaMK-II matches less than half of the aligned nucleotides in either zebrafish
camk2b2 MO. A mouse Tbx5 cDNA (Open Biosystems) was subcloned into the pCDNA3
vector. cDNA constructs (10–40 pg per embryo) were injected separately or co-injected with
MO's. A constant injection volume (~1 nl) was used per embryo and confirmed by volume
analysis.
Transfections and immunoblots
Tbx5-pCDNA3 or pCDNA3 alone was either transfected into NIH/3T3 mouse embryonic
fibroblasts using Lipofectamine 2000 (Invitrogen) as described (Caran et al., 2001) or injected
into zebrafish embryos. Two days after transfection, cell or embryo lysates were prepared as
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previously described (Rothschild et al., 2007). Equivalent amounts of soluble protein were
immunoblotted as described (Lantsman and Tombes, 2005) using 1 _g/ml cB_1 antibody for _
CaMK-II (Invitrogen), a pan-specific CaMK-II antibody which recognizes _ CaMK-II (BD
Biosciences) or an anti-actin peptide antibody (Sigma).
CaMK-II activity assay
Whole embryos were lysed and total CaMK-II activity was assessed by measuring
phosphate incorporation into the substrate, autocamtide-2, as previously described (Rothschild et
al., 2007).
Statistical analysis
Statistical analyses were performed using the paired t-test. For CaMK-II activity assays
and blot analysis, values from at least four replicates were used. Statistically significant
differences are denoted by an asterisk and P values indicated in figure legends. For zebrafish
embryo morphological features or heart rates, n values varied between 147 and 285 individuals.
Pectoral fins were assessed by integrating the bmp4-positive fin field area using digital image
analysis.
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RESULTS
Camk2b2 morphants resemble tbx5 morphants
The expression pattern of camk2b2 mRNAs in both the developing heart and pectoral fins
is reminiscent of a relatively limited number of genes including tbx5 (Garrity et al., 2002). In
addition, the camk2b2 morphant phenotype was similar to the hst mutant (Garrity et al., 2002)
and the tbx5 morphant (Ahn et al., 2002), particularly with respect to heart morphology and
function. Both tbx5 and camk2b2 morphants as well as KN-93 treated embryos exhibited an
elongated, more slowly beating heart (Supplemental Movie 1 and 2) accompanied by pericardial
edema  (Figure 3.1a-c; Figure 3.2a,b). Heart rates were decreased from 160 to 20bpm, half-
maximally at 4µM, which is the same concentration that half-maximally inhibits CaMK-II
activity in vitro (Figure 2.13). The myocardial marker cmlc2 (cardiac myosin light chain 2)
remained strongly expressed in both tbx5  and camk2b2 morphants and KN-93 incubated
embryos, but revealed an elongated myocardium that failed to undergo looping morphogenesis,
as shown at 48 hpf (Figure 3.1f–h; Figure 3.2c,d). The elongated heart was also visible in
camk2b2 and tbx5 morphants of cmlc2:DsRed transgenic embryos at 72 hpf (Figure 3.1k–m).
Like tbx5 mutants and morphants, camk2b2 morphants also displayed pectoral fin
defects. Although still present, pectoral fins were always stunted and occasionally asymmetric in
camk2b2 morphants and KN-93 treated embryos (Figure 3.1q,v; Figure 3.2e,f). In tbx5
morphants (Figure 3.1r, w) and mutants, pectoral fins were completely absent, indicative of an
early and essential regulatory role for Tbx5 in initiating forelimb development. The phenotypic
resemblance of the tbx5 and camk2b2 loss-of-function phenotypes suggested a genetic
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relationship between these two genes.
Tbx5 morphant heart defects can be rescued by cytosolic CaMK-II
The suggested genetic linkage between tbx5 and camk2b2 was assessed by co-injecting
morpholinos with a vector encoding GFP-linked human cytosolic _C CaMK-II. This co-injection
not only restored normal heart morphology and looping (Figure 3.1d,i,n) in camk2b2 morphants,
but also in tbx5 morphants (Figure 3.1e ,j, o). The CaMK-II variant (_C) used in this rescue had
both predicted insensitivity to the camk2b2 MO and an alternative domain structure similar to
zebrafish _2C (Figure 1b), which is one of the four camk2b2 variants detected by RT-PCR of
isolated zebrafish heart mRNA (data not shown). GFP-tagged _C CaMK-II exhibits normal
Ca2+/CaM-dependent catalytic activity and cytosolic localization (Caran et al., 2001) and was
detected by fluorescent microscopy throughout embryos, including heart cells through at least
the first four days of development (data not shown). Thus, restoration of CaMK-II activity via a
human splice variant with similarity to an endogenous zebrafish camk2b2 transcript was
sufficient to ameliorate cardiac defects in tbx5 morphants, as well as in camk2b2 morphants.
Normal fin morphology, however, was only rescued by ectopic expression of CaMK-II in
camk2b2 morphants, not tbx5 morphants (Figure 3.1s, x). In the wild type fin, bmp4 expression
was observed at the periphery (apical ectodermal ridge; AER) of the developing fin, as well as in
mesenchymal cells at the center of the fin field (Figure 3.1p, inset). In camk2b2 morphants,
bmp4 expression exists, but was limited to the mesenchymal area (Figure 3.1q, inset) of the
truncated fins. The wild type mesenchymal and AER pattern of bmp4 expression was restored,
however, when morphant embryos were co-injected with CaMK-II (Figure 1s, inset). In contrast,
neither fin development nor bmp4-expressing fin cells (Figure 3.1t, y) were observed in tbx5
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morphants, regardless of the level of CaMK-II injected; bmp4-positive cells in the pectoral fin
region are known to be absent in tbx5 morphants (Garrity et al., 2002).
Both tbx5 and camk2b2 MO's decreased heart rates by 40–50% at both 48 hpf and 72 hpf
(Figure 3.3a; Figure 3.2g), while both the mismatch MO and a MO directed against a related T-
box gene, tbx4 (Ahn et al., 2002), had no effect on heart rates. The similarity in the timing and
magnitude of the camk2b2 and tbx5 morphant phenotypes provides further support for a common
pathway. Heart rates of tbx5 morphants were recovered to near normal levels and such rescues
were dependent on the amount and activity state of co-injected CaMK-II (Figure 3.3b). For
example, constitutively active (T287D) CaMK-II (Ca2+-independent) was most effective at low
levels (20 pg), whereas wild type (WT) CaMK-II (Ca2+-dependent) rescued heart rates in
proportion to the amount injected. WT rescues were also more persistent beyond 72 hpf than
those rescued with T287D CaMK-II, which showed some reversion to the morphant phenotype.
This finding is consistent with Tbx5-dependent CaMK-II expression, not Ca2+ release.
Rescue experiments using 40 pg WT CaMK-II were summarized at 72 hpf (Figure 3.3c)
by determining the presence of circulation or heart looping and by measuring the fin field area
derived from bmp4 expression, as shown in Figure 3.1. Only 10–20% of camk2b2 or tbx5
morphant embryos exhibited circulation and looping, but this could be restored to 50–80% of
morphant embryos when co-injected with CaMK-II. The average fin field area in camk2b2
morphants was approximately 30% of that in control embryos and was restored to 90% by
CaMK-II co-injection. Tbx5 morphants exhibited no visible fins or bmp4-positive cells with or
without CaMK-II co-injection. Therefore, while CaMK-II expression is necessary and sufficient
to recover tbx5-induced cardiac defects, it is necessary but not sufficient to recover fin defects.
As predicted for a role in cardiac morphogenesis, we demonstrate that camk2b2 is
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expressed in myocardial cells by co-localization with cmlc2 using dual in situ hybridization
(Figure 3.4). Camk2b2 expression was more widespread in both atrium and ventricle than cmlc2,
but this is reminiscent of tbx5 expression, which is expressed in both myocardial and epicardial
cells of the human heart (Hatcher et al., 2001).
Levels of early cardiac and pectoral fin markers are unaffected in camk2b2 morphants
Both cardiac and paired limb progenitors derive from lateral plate mesoderm (LPM),
where Nkx2.5, GATA4 and other transcription factors are expressed to influence heart and/or
limb development (Chen and Fishman, 1996; Kelley et al., 1993; Martinez-Barbera et al., 1997;
Peterkin et al., 2007; Waxman et al., 2008). We therefore evaluated the influence of camk2b2
suppression on the expression levels of gata4 and nkx2.5 at the 8-somite stage. These important
early markers were unaffected in camk2b2 morphants (Figure 3.5 a–d) as previously shown for
tbx5 morphants (Garrity et al., 2002) indicating that the disruption in heart development occurs at
later times and not during cardiac specification. At the 21s and 24 hpf stages, heart cone (Figure
5e,f) and heart tube (Figure 3.5g,h) formation were unaffected in camk2b2 morphants as assessed
using cmlc2 expression. At 48 hpf, bmp4 expression was detected in both control hearts (Figure
5i) and in the elongated camk2b2 morphant hearts (Figure 3.5j). Representative thin sections
reveal an elongated cellular morphology, particularly in the atrium of camk2b2 morphant hearts
(Figure 3.5k,l). In camk2b2 morphant fins, bmp4 was expressed in a more concentrated patch of
cells (Figure 3.5n, arrows) than in control embryos, where bmp4 was preferentially expressed in
mesenchymal cells and at the AER of the developing fin (Figure 3.5m, arrows). Similarly, tbx5
expression levels in camk2b2 morphants remain unaltered (Figure 3.5p) when compared to
control embryos (Figure 3.5o), consistent with a role for Tbx5 upstream and not downstream of
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camk2b2.
Tbx5 mutant and morphants have reduced β CaMK-II expression
In further support of their relative genetic relationship, tbx5 morphant and mutant
embryos exhibit diminished cardiac and pectoral fin camk2b2 expression and lower total CaMK-
II activity levels (Figure 3.6). In tbx5 (Figure 3.6c,d), but not tbx4 morphants (Figure 3.6a,b),
camk2b2 expression was eliminated in the heart (v, a) and emerging pectoral fin fields (arrow
heads), but not in the somites or brain. This loss of camk2b2 expression was also observed in hst
mutant embryos (Figure 3.6g,h), but not siblings that lacked the hst morphology (Figure 3.6e,f).
In addition, CaMK-II enzymatic activity levels were measured in wild type, morphant and
mutant embryos at 72 hpf (Figure 3.6i). Either of two separate camk2b2 MO's (b2-A and b2-B)
decreased CaMK-II activity by over 75% relative to uninjected or tbx4 MO-injected embryos.
Morphant embryos co-injected with human CaMK-II, which is insensitive to zebrafish MO's,
exhibited a restoration of enzymatic activity proportional to the amount of cDNA injected. Both
tbx5 morphants (tbx5 MO) and the hst mutant (hst mut) embryos exhibited a 40–60% reduction
in CaMK-II activity when compared to control morphants, tbx4 morphants or non-mutant
siblings. Although camk2b2 expression is most likely subject to multiple transcriptional
influences, these findings indicate that Tbx5 promotes a subset of camk2b2 expression in the
heart and fins.
Tbx5 enhances β CaMK-II expression across species
In order to directly assess whether Tbx5 promotes _ CaMK-II expression, a cDNA encoding
mouse Tbx5 was transfected into NIH/3T3 cells. Tbx5 expression caused a two-fold increase in
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_ CaMK-II protein levels, but neither altered levels of _ CaMK-II, the most prevalent CaMK-II
in fibroblasts, or _-actin (Figure 3.7a). CaMK-II specific activity measurements, which
normalize activity to total protein, also showed a significant Tbx5-dependent increase (Figure
3.7b). When mouse Tbx5, which is 98% identical to zebrafish Tbx5 within the T-box domain
(Begemann and Ingham, 2000), was injected into embryos, a dose-dependent, but saturable,
increase in CaMK-II specific activity was observed (Figure 7c). These results indicate that Tbx5
acts across species to promote the expression of the _(2) CaMK-II gene. Tbx5 is believed to bind
to consensus sequence elements (TBE), defined as (A/G)GGTGT(C/G/T)(A/G) (Ghosh et al.,
2001; Sun et al., 2004a). At least one putative TBE was found 200 nt upstream of the start codon
in both zebrafish and mammalian _ CaMK-II genes, supporting the possibility that Tbx5 acts
either alone or in conjunction with other T-box family members (Naiche et al., 2005) to promote
the expression of this gene.
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DISCUSSION
_2 CaMK-II is induced by Tbx5 and is necessary for cardiac and limb morphogenesis
We conclude that _ CaMK-II expression is dependent on the T-box transcription factor,
Tbx5, and is necessary for the proper development of the heart and pectoral fins. This conclusion
is based on five distinct lines of evidence including: 1) the coincident temporal and spatial
expression of camk2b2 and tbx5 in heart and fins, 2) the similarity of camk2b2 and tbx5
morphant phenotypes, particularly in the heart, 3) the ability of cytosolic CaMK-II to rescue
cardiac defects in tbx5 morphants, 4) the sensitivity of CaMK-II expression to tbx5 suppression,
but not vice versa and 5) the induction of _ CaMK-II expression by ectopic Tbx5. While CaMK-
II has been implicated in adult cardiac function and remodeling (Anderson, 2007; Yang et al.,
2006; Zhang et al., 2005), this is the first report that supports a necessary role for CaMK-II in
cardiac and forelimb development.
Camk2b2 is the only one of the seven transcriptionally active CaMK-II genes in zebrafish
embryos whose embryonic expression pattern is consistent with a role in the maturation of the
heart and pectoral fins. Camk2b2 mRNAs are also expressed in the developing brain and
somites, but tbx5 suppression does not diminish camk2b2 brain expression. Consistent with this
finding and unlike tbx5 mutants and morphants, camk2b2 morphants have reduced head size and
distorted trunks, in addition to their heart and fin defects. Ectopic human cytosolic _ CaMK-II
reverses all of these developmental defects, which is consistent with cytosolic roles for all
embryonic camk2b2 variants. Although _2 CaMK-IIs could hetero-oligomerize with other
CaMK-IIs, which may target the holoenzyme to other sub-cellular locations, this result
demonstrates that CaMK-IIs exhibiting the same targeting domain structure can functionally
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substitute for each other between genes and species.
Potential mechanisms of _2 CaMK-II action in heart and fin morphogenesis
Camk2b2 expression in the heart is coincident with heart looping, a process potentially
influenced by cell migration, proliferation and apoptosis (Ahn et al., 2002; Garrity et al., 2002;
Goetz et al., 2006; Yelon, 2001 ). Cardiac cone and tube morphology in camk2b2 morphants is
unaltered at 24 hpf, but the transition to a looped heart over the next 24 h is blocked. Non-
canonical Wnt (ncWnt) family members, including Wnt5 (Slusarski et al., 1997) and Wnt11, but
not canonical Wnt8 (Westfall et al., 2003b), induce Ca2+ elevations in zebrafish embryos and
have been implicated in both convergent extension cell movements and in cardiac
morphogenesis (Kohn and Moon, 2005; Kuhl et al., 2000a; Kuhl et al., 2000b; Sheldahl et al.,
2003). These ncWnts are believed to activate CaMK-II (Kohn and Moon, 2005; Kuhl et al.,
2000a; Kuhl et al., 2000b; Sheldahl et al., 2003) and defects in convergent extension in the Wnt5
pipetail mutant (ppt) (Kilian et al., 2003) and in knockdowns of its receptor, frizzled2 (Sumanas
et al., 2001), can be partially rescued with ectopic CaMK-II (Westfall et al., 2003a). Wnt11,
possibly acting in conjunction with the Na+/Ca2+ exchanger, NCX, and/or SERCA2, the
sarcoplasmic reticulum (SR) Ca2+ ATPase, may contribute to the Ca2+ release necessary to
activate _2 CaMK-II.
Loss of either Tbx5 or CaMK-II disrupts cardiac morphogenesis, but does not diminish
the expression of early genes that specify cardiac tissue, such as those encoding Gata4, Nkx2.5
and Bmp4. This is also consistent with studies that have demonstrated that the expression of
these genes in Xenopus is insensitive to the CaMK-II inhibitor, KN-93 (Pandur et al., 2002).
Although tbx5 is expressed in lateral plate mesoderm (Ahn et al., 2002; Garrity et al., 2002) and
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induces the expression of many early genes important for cardiac development, it is likely that
Tbx5 collaborates with independently induced transcription factors (Brown et al., 2005; Clark et
al., 2006; Naiche et al., 2005) to promote camk2b2 expression in the looping heart or coalescing
fin field. The expression of other Tbx5-dependent genes in the heart, such as connexin (Clark et
al., 2006) are necessary to maintain the differentiated heart phenotype initially achieved through
CaMK-II expression and activity.
In the developing fin, camk2b2 is expressed subsequent to limb bud initiation, which occurs
around 26 hpf (Grandel and Schulte-Merker, 1998), but simultaneous with creation of the apical
fold at 36 hpf and continuing through 48 hpf, when mesenchymal cell migration is prevalent
(Grandel and Schulte-Merker, 1998). This is also consistent with a role for CaMK-II in
morphogenesis, not specification of fin cells. The inability of CaMK-II to rescue tbx5 morphant
fin defects is consistent with a requirement for additional critical Tbx5-dependent genes, such as
FGFs and Wnts, in forelimb bud initiation (Harvey and Logan, 2006; Rallis et al., 2003;
Takeuchi et al., 2003).
Specifically, CaMK-II could influence cardiac and limb morphogenesis through its
known roles in cell cycle progression or cell migration. Both extrinsic physical forces and
intrinsic cellular fates influence cardiac morphogenesis (Auman et al., 2007). The mechanism of
CaMK-II action must be through transient or cyclical Ca2+-dependent catalytic activity, since
excessive constitutively active CaMK-II is incapable of rescuing mutant phenotypes. Both the
natural cycle of contraction as well as morphogens must be considered as triggering the Ca2+
sources necessary to activate CaMK-II.
CaMK-II is known to promote progression of fibroblasts through the G1 phase of the cell
cycle (Morris et al., 1998) possibly through its activity-dependent interaction with the TCF
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transcriptional co-regulator, flightless-I (Seward et al., 2008). This is consistent with the reported
cardiac cell cycle delay in G1 or early S-phase caused by Tbx5 depletion in Xenopus (Goetz et
al., 2006). Both the depletion of Tbx5 and prolonged inhibition of CaMK-II lead to apoptosis
(Goetz et al., 2006; Tombes et al., 1995). CaMK-II may influence morphogenesis through
balanced effects on proliferation and apoptosis in embryonic cardiac and fin cells.
Alternatively, CaMK-II may influence morphogenesis by regulating directional cell
migration as previously suggested for both heart (Schoenebeck and Yelon, 2007) and fin
(Grandel and Schulte-Merker, 1998) development. Tbx5 has been implicated in proepicardial
cell migration in the chick embryo (Hatcher et al., 2004) and CaMK-II is known to influence the
migration of vascular smooth muscle cells (Lundberg et al., 1998; Pfleiderer et al., 2004) and
fibroblasts (Easley et al., 2008). CaMK-II could also influence migration through direct
phosphorylation of Tiam1, a guanine nucleotide exchange factor for Rac1 (Fleming et al., 1999;
Fleming et al., 1998) or through its promotion of phosphotyrosine turnover of the focal adhesion
proteins, paxillin and FAK (Easley et al., 2008). The tyrosine phosphatase, SHP-2,
dephosphorylates FAK and paxillin, to promote focal adhesion turnover (Ren et al., 2004;
Vadlamudi et al., 2002) and has been linked to human heart and limb development through SHP-
2 mutations identified in Noonan or Leopard syndrome (Digilio et al., 2002; Poole and Jones,
2005; Tartaglia and Gelb, 2005; Tartaglia et al., 2001). Targeted mutations in SHP-2 based on
actual Noonan and Leopard syndrome patients also yield a phenotype reminiscent of heartstring
(Jopling et al., 2007). Altered directional cell migration could explain the observed phenotypes
of stretched cardiac cells and disrupted fin cell dispersal observed in camk2b2 morphants.
Finally, a mechanism by which cytosolic CaMK-II could influence the expression of
genes required for morphogenesis comes from evidence that cytosolic CaMK-IIs influence the
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localization of histone deacetylases (HDAC) in cardiomyocytes (Backs et al., 2006). HDAC1
and HDAC2 are both necessary for mouse cardiac morphogenesis (Montgomery et al., 2007),
zebrafish HDAC1 morphants exhibit heart and fin defects (Pillai et al., 2004) and mouse HDAC1
and 2 knockouts result in the derepression of many genes, some of which are implicated in cell
motility and cell structure (Montgomery et al., 2007). Therefore, cellular roles for CaMK-II in
coordinating gene expression, migration, proliferation and apoptosis may all contribute to the
morphogenesis of heart and limbs.
In summary, Tbx5 promotes the expression of camk2b2 around 36 hpf in the heart as it is
undergoing looping and in the fins at the time of mesenchymal cell migration. Although both
tbx5 and camk2b2 expression persist beyond 48 hpf, the expression of camk2b2 in the heart is
more transient than fin expression, suggesting that the transcriptional co-regulators that
collaborate with Tbx5 in heart and fins are subtly different. Once _2 CaMK-II is expressed, the
source of activating Ca2+ and the binding partners or substrates through which CaMK-II
influences heart and fin morphogenesis remain undefined.
Implications to human cardiac disease
A role for CaMK-II in embryonic morphogenesis, as described in this study, is consistent
with its proposed function in maintenance of the adult heart. Excess cardiac CaMK-II in
transgenic mice hyperactivates SERCA which, inhibits proper Ca2+ release and reuptake from the
sarcoplasmic reticulum; resulting in cardiomyopathy and heart failure (Zhang et al., 2003). In
fact, inhibition of CaMK-II activity represents a clinically relevant mechanism for suppressing
the pathological remodeling of adult heart tissue (Zhang et al., 2005). Optimal levels of CaMK-II
activity are therefore important for the morphogenesis, maintenance and function of both the
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embryonic and adult heart. CaMK-II suppression provides a plausible explanation for both
bradycardia and aberrant cardiac development observed in tbx5 morphants (Garrity et al., 2002)
and in individuals with Holt–Oram syndrome (Clark et al., 2006).
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Figure 3.1. Tbx5 heart defects can be rescued by CaMK-II. Wild type or cmlc2:DsRed
transgenic embryos (k–o) were injected with the mismatch MO (5 ng), camk2b2 MO (2 ng) or
tbx5 MO (5 ng) with or without 40 pg wild type _E CaMK-II cDNA and imaged at 72 hpf (a–e;
k–y) or subjected to cmlc2 in situ hybridization at 48 hpf (f–j). Scale bar = 0.5 mm and anterior
is to the left. In f and k, a = atrium and v = ventricle. In p–t, insets reveal bmp4 in situ
hybridization patterns in the pectoral fin area. In u–y, brackets indicate extent of pectoral fin
length.
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Figure 3.2. Pharmacological suppression of CaMK-II alters heart and fin development.
Embryos treated with 10 µm KN-93 starting at cleavage stages were imaged at 72hpfpf to look at
heart and fin development. KN-93 treated embryos had linear hearts as shown by DIC images at
72hpf (a,b) and cmlc2 expression (c,d) at 48hpf.  Fin development was also disrupted as shown
by lateral views (e,f, bracket). Heart rates were assessed with increasing concentrations of KN-93
in 72hpf embryos. Scale bar=0.5mm.
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Figure 3.3. Summary of camk2b2 and tbx5 rescues. (a) Heart rates were averaged at 48 and 72
hpf after injection with 5 ng tbx4, 5 ng tbx5 or 2 ng camk2b2 MO (beta2), n = 147–158 per
condition. (b) Heart rates were averaged at 72 hpf after injection with 5 ng tbx5 MO plus the
indicated pg of WT or T287D _E CaMK-II cDNA, n = 56–62 per condition. (c) Summary: n =
88–187 per condition. Embryos injected with 2 ng of either camk2b2 MO (b2) or 5 ng tbx5 MO
plus or minus 40 pg wild type _E CaMK-II cDNA were scored at 72 hpf for the presence of
absence of circulation or heart looping and shown as a percentage of all embryos. Fin field area
was assessed at 72 hpf from bmp4 in situ hybridization and is presented as a percentage of the fin
field area in tbx4 morphant embryos.
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Figure 3.4. Co-localization of camk2b2 with cmlc2. Camk2b2 (Cy3, red) or cmlc2 (Alexa 488,
green) expression was assessed by in situ hybridization and confocal fluorescent microscopy and
then merged in 36 hpf atrial (a–c), 36 hpf ventricular (d–f) and 48 hpf ventricular (g–i) samples.
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Figure 3.5. Early genes responsible for heart and fin specification are expressed in camk2b2
morphants. Gata4 and nkx2.5 expression in the lateral plate mesoderm at the 8-somite stage
(a–d), cmlc2 at 21s (e, f) and 24 hpf (g, h), bmp4 at 48 hpf (i, j, m, n) and tbx5 at 48 hpf (o, p)
were determined by in situ hybridization for embryos injected with 5 ng camk2 mismatch MO or
2 ng camk2b2 MO. Thin sections of cardiac tissue from mismatch or camk2b2 morphants were
stained with methylene blue (k, l). Anterior is to the left in all views.
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Figure 3.6. Tbx5 morphants and mutants decrease CaMK-II levels. Camk2b2 in situ
hybridization of 36 hpf embryos injected with 5 ng tbx4 MO (a, b) or 5 ng tbx5 MO (c, d) or
uninjected hst siblings (e, f) and hst mutants (g, h) as determined phenotypically. Dorsal views
(a, c, e, g) mark fins with arrow heads and head on views (b, d, f, h) mark atrium and ventricle.
Scale bar = 0.2 mm. (i) CaMK-II activity was assessed at 72 hpf in at least 5 embryos per
condition by CaMK-II peptide assay in the presence of Ca2+/CaM. Conditions include uninjected
embryos (Uninj), camk2b2 MO A and MO B embryos at 2 ng (b2-A and b2-B), embryos co-
injected with 2 ng camk2b2 MO B and 40 pg wild type _E CaMK-II cDNA (b2 MO + CaMK),
tbx4 and tbx5 morphants (5 ng), hst embryos with (_/_) the hst phenotype (hst mut.) and siblings
without (+/_; +/+) the hst phenotype (hst norm.)
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Figure 3.7. Tbx5 promotes _2 CaMK-II Expression. (a) _ CaMK-II, _ CaMK-II and actin
immunoblots of 10 _g NIH/3T3 lysate from cells which had been transfected with Tbx5-
pCDNA3 or empty pCDNA3 vector. (b) CaMK-II specific activity (in pmol/min/mg) and
integrated blot densities (normalized) from NIH/3T3 cells were averaged from four separate
transfections and are shown with standard deviations. (c) Zebrafish embryos were injected with
the indicated amount of pCDNA3 or Tbx5-pCDNA3 and activity assays performed at 72 hpf.
Asterisks indicate P < 0.005.
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Supplemental Movies
Supplemental Movie 1 - Morphant phenotypes. A series of three short time lapse videos of
embryonic hearts and circulation, 3 days post fertilization after injection with (a) 2 ng of control
(mismatch) MO, (b) 1 ng camk2b2 MO and (c) 2 ng camk2b2 MO.
Supplemental Movie 2 - Morphant phenotypes. Two short time lapse videos of embryonic hearts
3 days post fertilization after injection with (a) 2.5 ng of camk2b2 MO and (b) 5 ng tbx5 MO.
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Chapter 4:  PKD2 Ca2+ Activates CaMK-II to Abrogate Cyst Formation in a Zebrafish
Model of ADPKD
ABSTRACT:
γ1 CaMK-II was next analyzed since it is expressed at high levels during cleavage stages and has
unique expression patterns during development.  Interestingly, camk2g1 is the only CaMK-II
gene expressed in the developing embryonic kidney (pronephros). Ca2+ signaling is known to be
important during kidney development and to maintain homeostasis in the nephron as an adult.
Several kidney diseases have been linked to alterations in Ca2+ signaling including, autosomal
dominant polycystic kidney disease (ADPKD), which affects 5-6 million people worldwide and
is the most common monogenetic kidney disease.  Mutations in two genes, PKD1 and PKD2,
have been linked to ADPKD. PKD1 is a large transmembrane protein that forms a receptor
channel complex with PKD2 to facilitate Ca2+ entry into the cytosol. These mutations cause
alterations in Ca2+ signaling pathways leading to hyperproliferation, apoptosis, loss of cellular
polarity, and ultimately the formation of massive fluid filled cysts.  Understanding the
downstream Ca2+ effectors could aid in finding viable treatments for patients with ADPKD. This
study identifies CaMK-II as a target of PKD2 Ca2+ in the zebrafish pronephros.  Suppression of
camk2g1 causes cloacal obstructions, which ultimately leads to the development of cysts. This
camk2g1 morphant phenotype mirrors suppression of pkd2 in zebrafish embryos. Ectopic
expression of constitutively active, not wild type, CaMK-II reverses cystic development,
supporting a dependence on Ca2+ release, not CaMK-II expression in pkd2 morphants.
Furthermore, suppression of pkd2 leads to decreased levels of active CaMK-II in the distal
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pronephric duct and a 40% reduction in Ca2+-independent activity in manually dissected
pronephros. Actin organization and localization is disrupted in camk2g1 morphants, while other
markers of polarity are normal leading to the hypothesis that PKD2 Ca2+ activates CaMK-II to
stabilize F-actin in the apical membrane of the zebrafish embryonic kidney.
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INTRODUCTION
Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common
monogenetic kidney disease affecting 1 in 1,000 births and is typified by the development of
massive kidney cysts. Approximately 10% of cases in the United States lead to end-stage renal
disease (Wilson and Falkenstein, 1995). A systemic disorder, cysts also develop in the pancreas
and liver, and cardiovascular defects arise including an increased risk for aortic aneurysms
(Chapman et al., 1993; Gabow, 1993; Milutinovic et al., 1984; Wilson and Falkenstein, 1995).
ADPKD is caused by mutations in two transmembrane proteins, PKD1 and PKD2 (Harris et al.,
1995; Hughes et al., 1995; Igarashi and Somlo, 2002; Wilson, 2004a). PKD1 encodes polycystin-
1, a large receptor-like integral membrane protein with an extracellular N-terminus that contains
motifs for cell-cell and cell-matrix interactions, as well as a receptor for egg jelly homology
domain (REJ) and a GPCR proteolytic site (GPS) (Wilson, 2004a). REJ is a glycoprotein
responsible for the acrosome sperm reaction during sea urchin fertilization (Moy et al., 1996).
The REJ domain is thought to be essential for proteolytic cleavage that occurs at the GPS (Qian
et al., 2002). PKD2 encodes polycystin-2, a member of the TRP superfamily of nonselective
Ca2+-permeable ion channels (Clapham, 2003; Mochizuki et al., 1996). PKD2 functions at the
plasma membrane, endoplasmic reticulum, and in the primary cilium to alter intracellular Ca2+
concentrations, activating effector proteins to drive cellular processes (Cai et al., 1999; Kottgen,
2007; Tsiokas, 2009; Tsiokas et al., 2007). Both PKD1 and PKD2 contain a coiled-coil domain
in the intracellular C-terminus to allow for the formation of a receptor-channel complex
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(Casuscelli et al., 2009; Qian et al., 1997). This complex is thought to play a major role in
regulating levels of intracellular Ca2+, where activation of PKD1 induces Ca2+ entry via PKD2
(Hanaoka et al., 2000; Vandorpe et al., 2001).
The identification of both pkd1 and pkd2 mutations in patients with ADPKD has yielded
the hypothesis that the two genes are necessary and act in the same molecular pathway for the
development of normal renal parenchyma. Interestingly, both a germ-line mutation and a somatic
mutation are necessary to develop cystic kidneys, which has led to a two-hit model of
cystogenesis (Kottgen, 2007; Pei et al., 1999). This theory explains why the severity of cyst
development varies between patients with an identical allelic mutation. The complexity of this
condition has currently hindered the ability to generate treatments for patients. Symptoms, such
as high blood pressure, are managed with drugs and cystic development is watched closely but
cannot be suppressed. Therefore, it is important for scientists to continue to identify downstream
pathways that are essential in the maintenance of normal renal tissue, so pharmacological
treatments can be generated that will abrogate the formation of cysts and cardiovascular defects
Animal models of ADPKD   
Genetic manipulation strategies have been implemented in model systems to obtain
insights into the molecular mechanism(s) of ADPKD. Homologs for both PKD1 and PKD2 have
been identified in mice and zebrafish (Mangos et al., 2010; Obara et al., 2006; Roelfsema and
Breuning, 1996; Wu et al., 1998). Mice homozygous for mutations in either pkd1 or pkd2 usually
die prior to E16.5 due to development of cysts in the kidney and pancreas, while heterozygous
carriers generally develop cysts as adults (Lantinga-van Leeuwen et al., 2004; Lantinga-van
Leeuwen et al., 2007; Lu et al., 1999; Lu et al., 1997; Wu et al., 1998). In addition mouse pkd2
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knockouts develop cardiac abnormalities and situs inversus, a reversal of visceral organ
placement (Pennekamp et al., 2002; Wu et al., 1998). Mice that have lowered expression of
PKD1 also develop cystic kidneys demonstrating the requirement for a specific concentration of
PKD1 to maintain normal renal development (Lantinga-van Leeuwen et al., 2004). Interestingly,
a PKD rat model treated with a Ca2+ channel blocker increased cystic development, whereas a
Ca2+ mimetic inhibited late stage cystic development (Gattone et al., 2009; Nagao et al., 2008).
This suggests that the decrease in intracellular Ca2+ in PKD mutants causes the formation of
kidney cysts.
Zebrafish develop a functioning pronephros by 48hpf, and can survive in the absence of
blood flow for five days making this an idea system to study cystic diseases (Drummond, 2003;
Drummond, 2005; Yelon, 2001 ). Suppression of pkd2 in zebrafish results in hydrocephaly, loss
of left-right asymmetry, a curved body, cloacal occlusions and pronephric cysts, while
knockdown of pkd1 causes tail curvature and pronephric cysts (Mangos et al., 2010; Obara et al.,
2006; Schottenfeld et al., 2007). Similarly, injection of mRNA encoding pkd2 that either lacks
the coiled-coil domain or inhibits Ca2+ channel activity develops pronephric cysts in zebrafish
(Feng et al., 2008). Interestingly the absence of the PKD1 C-terminal tail has been found to
cause cyst development in lipid bilayers and Xenopus oocytes, while the overexpresion of the
PKD1 C-terminal tail causes cysts in zebrafish embryos (Aguiari et al., 2003; Low et al., 2006;
Vandorpe et al., 2001).
Animal models of polycystic kidney disease demonstrate the requirement for coordinated
regulation of kidney development. Proliferation, apoptosis, polarity, migration, and cellular
morphology are important processes that have to be balanced to form normal tissue.  Absence of
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intracellular Ca2+ disrupts this balance leading to cystic development. Identifying the
downstream effector(s) will aid in identifying therapeutic targets for ADPKD.
Cellular mechanisms involved in ADPKD pathology:
Proliferation and apoptosis
A balance between proliferation and apoptosis is necessary to maintain a functioning
kidney. Dissection of cystic kidneys revealed an increase in epithelial cell number around cysts
(Grantham et al., 1987). Ca2+ channel dead PKD2 mutants proliferate faster and EGF-stimulated
proliferation is increased in cells that lack PKD2 (Grimm et al., 2006). These results point to
PKD2 as a negative regulator of cell proliferation. However, tubular epithelial cell apoptosis is
also increased in animal models of ADPKD and in human kidneys of patients with ADPKD
(Woo, 1995).  Caspase inhibition has been shown to reduce cystic development in animal models
of cystic kidney disease (Tao et al., 2005a; Tao et al., 2005b; Tao et al., 2008). It is believed that
healthy kidney tissue undergoes apoptosis to allow for the cystic tissue to proliferate,
demonstrating the requirement for both mechanisms in the development of ADPKD pathology.
Cilia
The localization of PKD1 and PKD2 to the primary cilium has generated compelling
evidence that this complex may act as a flow sensor, where bending of the cilia is associated with
an influx of Ca2+ into the cell (Praetorius and Spring, 2001; Praetorius and Spring, 2003; Yoder
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et al., 2002). Mutations in ciliary assembly proteins, ift88 and kif3a, fail to develop motile cilia
and lack fluid flow causing the formation of kidney cysts in zebrafish and mice (Colantonio et
al., 2009; Lin et al., 2003; Vasilyev et al., 2009). ADPKD cyst epithelia cells fail to initiate flow
sensitive Ca2+ signaling pathways that are essential in maintaining kidney homeostasis (Nauli et
al., 2003). ADPKD patients with mutations in PKD2 have reduced ER Ca2+ stores as well as an
overall loss of intracellular Ca2+ (Hooper et al., 2005; Yamaguchi et al., 2006; Yamaguchi et al.,
2004). In addition, calcium induced calcium release (CICR) from the ER, either through ER
localized PKD2 or IP3R, normally causes a rise in intracellular Ca2+ thereby activating
downstream pathways (Li et al., 2005). Although intracellular Ca2+ increases, the downstream
effector proteins that help maintain normal function and prevent cyst formation have yet to be
identified (Kottgen, 2007).
Polarity
Analysis of patients with ADPKD found that adult renal cells revert to a fetal epithelial
organization, where the normally polarized proteins, EGFR and Na+/K+-ATPase, are mislocalized
to the apical membrane (Burrow et al., 1999; Wilson et al., 2000). Cystic zebrafish mutants, such
as fleer  and big league chew, also mislocalize Na+/K+-ATPase to the apical membrane
(Drummond et al., 1998). PKD2 is mislocalized from the basolateral membrane in pkd2
morphants or embryos ectopically expressing pkd2 mutations (Feng et al., 2008; Obara et al.,
2006). Non-canonical Wnt signaling pathways also play a role in establishing apico-basolateral
polarity; mice lacking Wnt9b lose planar cell polarity and develop cystic kidneys (Karner et al.,
2009). Other core planar cell polarity proteins also lead to pronephric cysts when suppressed in
zebrafish (Skouloudaki et al., 2009). It is reasonable to believe that a balance between cellular
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proliferation, apoptosis and polarity maintain normal kidney homeostasis. A subtle disruption in
this equilibrium could lead to cystogenesis in patients with ADPKD.
Summary
Although many studies demonstrate that PKD2 is important in regulating intracellular
Ca2+ levels, few studies have identified the downstream effector. A recent study in the Tombes
lab has identified CaMK-II as a downstream mediator of PKD2 Ca2+ in the Kupffer’s Vesicle
(KV), the ciliated organ necessary for establishment of left/right asymmetry. Knockdown of
pkd2 caused a reduction in and mislocalization of active CaMK-II around the KV resulting in
randomization of southpaw expression in the lateral plate mesoderm (Francescatto et al., 2010).
This work is the first to identify a Ca2+-dependent protein downstream of PKD2.
Evidence is presented here that CaMK-II is the target of PKD2 Ca2+ in the developing
zebrafish kidney. Active CaMK-II is found in the zebrafish pronephric duct beginning at 24hpf,
peaks at 30hpf, and remains through 3dpf. Suppression of γ1 CaMK-II induces hydrocephaly,
cloacal occlusions, pronephric cysts, loss of left-right asymmetry, and defects in ear
development. Knockdown of PKD2 inactivates CaMK-II and ectopic expression of CaMK-II in
pkd2 morphant embryos partially reverses the cystic phenotype. CaMK-II is expressed and
localized at the perfect time to be the ideal signaling molecule that decodes intracellular Ca2+
signals initiated by morphogenesis or physiological stimuli to maintain kidney homeostasis
during development.
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MATERIALS AND METHODS
Zebrafish strains and care
Wild type (AB and WIK), Tg(α1 subunit Na+K+ATPase:GFP) and Tg(β-actin:CAAX-
GFP) fish embryos were obtained through natural matings, raised at 28.5°C as previously
described (Kimmel et al., 1995).
Whole mount in situ hybridization
Digoxigenin-labeled anti-sense riboprobes (0.5–1.5 kb) were synthesized using T3 or T7
RNA polymerase from cloned cDNAs, hybridized with fixed embryos and then developed using
alkaline phosphatase-conjugated anti-digoxigenin antibodies as described in chapter 2. The
generation of gata3, cdh17, wt1a, and ret1 were completed as previously described (Wingert and
Davidson, 2008; Wingert et al., 2007). A plasmid encoding the pax2a cDNA was linearized
using Not1 and transcribed with Sp6 RNA polymerase. A γ1c antisense probe was generated
from 48hpf kidney cDNA, TOPO cloned, linearized with Not1 and transcribed using the T3
RNA polymerase. Fluorescent in situ hybridization was conducted as described in chapter 3.
Fluorescent images were acquired using a NIKON C1 laser scanning confocal microscope.
CaMK-II antibodies
Immunolocalization using anti-phosphorylated (Thr287) CaMK-II has previously been
described by this laboratory (Easley et al., 2006). All zebrafish CaMK-IIs have a sequence of
MHRQE[pT287]VECLK in this region (Rothschild et al., 2009; Rothschild et al., 2007), which is
very similar to the phosphopeptide antigen used to create this rabbit polyclonal antibody
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(MHRQE[pT]VDCLK; Upstate/Millipore) and are therefore predicted to cross-react. The
underlined glutamic acid (E) in zebrafish is the only (conservative) change (from the underlined
aspartic acid (D)) in the epitope. This antibody has been shown to react with autophosphorylated
(P-Thr287) mammalian CaMK-II (Rich and Schulman, 1998). The pan-specific mouse
monoclonal antibody (total CaMK-II) used in this study (BD Biosciences) was determined by
immunoblot to be reactive with all ectopically expressed zebrafish CaMK-IIs tested so far
including α1KAP, δ1G and β1K, although it was not sufficiently reactive to detect total CaMK-II
in whole mount embryos until ~24hpf.
Pronephric dissection and flow sorting
For pronephric dissection Na+/K+-ATPase:GFP-transgenic embryos at 24, 48, and 72hpf
were anesthetized and incubated in 10mM DTT for one hour in egg water. After several washes
in egg water embryos were incubated in 5mg/ml collagenase for 3-6 hours at 28.5°C in DMEM.
After gently pipetting embryos, the dissected pronephros were manually extracted under GFP
epifluorescence illumination on a Nikon AZ100 stereoscope and placed into 1xPBS (Liu et al.,
2007). Dissected pronephros were dissolved in Trizol Reagent (Invitrogen) to make RNA or
harvested for CaMK-II activity assays as previously described in Chapter 2 (Rothschild et al.,
2009; Rothschild et al., 2007).  For flow sorted kidney cells, embryos were incubated in
collagenase as described above for 6 hours then placed into 0.25% trypsin/EDTA for 30 minutes
at 28.5°C. Embryos were filtered through mesh prior to sorting on a Becton-Dickinson FACS
Aria II high-speed analyzer/sorter. Na+/K+-ATPase:GFP positive cells were dissolved in Trizol
to generate RNA as stated above.
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CaMK-II activity assay
Whole embryos were lysed or GFP pronephros were obtained and total CaMK-II activity
was assessed by measuring phosphate incorporation into the substrate, autocamtide-2, as
previously described (Rothschild et al., 2007).
Immunolocalization
Embryos were fixed in 4% paraformaldehyde (Phalloidin) in PBS and stored in methanol
(P-CaMK-II, total CaMK-II, and acetylated tubulin) or fixed in Dent’s fixative (80:20
Methanol:DMSO) (kidney specific alpha−1 subunit Na+K+-ATPase (α6F), atypical protein
kinsae C (aPKC), and γtubulin). Embryos were incubated with rabbit anti-phospho-Thr287
(Millipore) (1:20), mouse anti-total CaMK-II (BD Biosciences) (1:20), mouse anti-acetylated α-
tubulin antibody (Sigma Chemical Co.) (1:500), mouse anti-α6F (Developmental Studies
Hybridoma Bank, University of Iowa) (1:10), rabbit anti-aPKC (Santa Cruz) (1:10), or mouse
anti-γtubulin (Sigma Chemical Co.) (1:500) followed by either goat anti-mouse Alexa488, goat
anti-mouse Alexa568, or goat anti-rabbit Alexa568 (Invitrogen) (1:500). Embryos were
permeabilized using NP-40 prior to the addition of Alexa-488 phalloidin (Invitrogen) (1:50).
Embryos were imaged using confocal microscopy (Nikon C1 Plus two-laser) on a Nikon E-600
compound microscope using a 100X oil immersion objective.
mRNA generation
Vectors encoding cytosolically targeted wild type and constitutively active (T287D)
CaMK-II δE in pCDNA3 were linearized using AvrII and transcribed using the T7 mMessage kit
(Ambion).
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Immunoblot
Dissected pronephros were lysed and prepared as described above. Equivalent amounts of
soluble protein were immunoblotted as described (Lantsman and Tombes, 2005) using 1 _g/ml
P-CaMK-II antibody (Millipore), and a pan-specific CaMK-II antibody (BD Biosciences).
Morpholino and cDNA injections
The zebrafish pkd2 MO (5’-AGGACGAACGCGACTGGAGCTCATC-3’) was
previously described and was purchased from GeneTools (Philomath OR) (Sun et al., 2004b).
The camk2g1 MO was described in chapter 2. Morpholino stocks (1mM) were stored in aliquots
at -80ºC. Prior to injection, aliquots were heated to 65ºC for 5 min, cooled to room temperature
and then diluted in Danieau buffer. 4.5pg and 1pg of MO was injected into embryos at the 1-4
cell stage for pkd2 and camk2g1. A constant injection volume of 1nl was measured prior to
injection. Co-injection of CaMK-II δE was described in chapter 3.
High speed video microscopy
Live embryos were imaged using differential interference contrast optics after transient
anesthesia with 0.003% Tricaine (MS222, Sigma) and immobilization between coverslips.
Ciliary motility was imaged in the kidney and otic vesicle of live, anesthetized embryos using a
NIKON 60X water immersion Plan APO objective with DIC optics and 25 frames per second
acquisitions. Lengths of cilia in fixed embryos were determined from anti-acetylated α-tubulin
whole mounts using quantitative length algorithms in Nikon Elements version 3 experimental
replicates for at least ten embryos per replicate. Statistical analyses were performed using the
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paired t-test. Statistically significant differences are denoted by an asterisk and indicated P-
values.
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RESULTS
Activated CaMK-II localizes to the CNS, embryonic kidney and ear
To determine tissue localization of total and activated CaMK-II two well-characterized
antibodies were used; the first detects all CaMK-II and is reactive with the C-terminal region,
while the second recognizes phosphorylated T287, the autophosphorylation site responsible for
autonomous CaMK-II activity (Easley et al., 2006). The specificity of the antibody was
established by overexpression of zebrafish CaMK-II in mPCT cell culture. CaMK-II activation
was determined by P-CaMK-II and total CaMK-II immunoblots after autophosphorylation over
time on ice. The resulting blot demonstrated that the level of total CaMK-II remained the same
but the level of immunoreactivity with the P-CaMK-II antibody was proportional to autonomy
(Francescatto et al., 2010).
Since CaMK-IIs are enriched in the central nervous system, it was not surprising that
total CaMK-II was first detected in the brain and spinal cord. 30hpf zebrafish embryos express
CaMK-II in the forebrain region and in both cells and axonal projections of the telencephalon as
shown by co-localization with acetylated tubulin (Figure 4.1a-d). Interestingly, certain cell
clusters have high levels of total CaMK-II but little active CaMK-II, identifying different
activation states. Expression of highly active CaMK-II, but not acetylated tubulin, in axonal
projections may demonstrate the need for CaMK-II in axonal pathfinding in vivo, given that
acetylated tubulin is required for axon stabilization (Figure 4.1d). In addition, CaMK-II was also
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identified in cell bodies of spinal cord sensory neurons (Figure 4.1e-g), but was absent from
sensory axons (Figure 4.1h).
High levels of total CaMK-II and low levels of highly active CaMK-II were found in the
muscle sarcomeres within the somites (Figure 4.1i-k). CaMK-II is important in muscle
contractions through ryanodine receptor phosphorylation, which cause Ca2+ extrusions from the
ER. This process requires CaMK-II to be activated and inactivated quickly to generate the
cyclical release and reuptake of Ca2+ from the ER. This rapid activation and deactivation would
limit the amount of highly active CaMK-II in these cells (Maier and Bers, 2002; Schneider and
Rodney, 2004).
The identification of CaMK-II in the kidney (pronephros) and embryonic ear (otic
vesicle) was unexpected. The pronephros is the larval kidney that functions to filter blood and
remove waste. Active CaMK-II was identified on the apical face of cells lining the pronephric
ducts (Figure 4.1j) and on all cortical sides of cells (Figure 4.1l). Total CaMK-II levels were low
but visible, demonstrating a high level of Ca2+ independent activity within the pronephros
(Figure 4.1i). In the otic vesicle, total CaMK-II was enriched in the cells from which emerge the
kinocilium, an organelle necessary for otolith formation and hearing. Zebrafish otoliths are
similar to mammalian otoconia, which are “stones” of the inner ear necessary for balance and
hearing.  Active CaMK-II was enriched at the base of the kinocilium and was also found
throughout the cytosol. The identification of highly active CaMK-II in ciliated organs may point
to a role for CaMK-II in preventing “ciliopathies” such as deafness and cystic kidney diseases
(Fliegauf et al., 2007; Nigg and Raff, 2009).
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Differential activation of CaMK-II along the zebrafish kidney
The zebrafish pronephros is the first kidney to form and function to filter blood through
the larval stage of development.  It is composed of two nephrons with two glomeruli fused at the
midline. Pronephric tubules connect the glomeruli to pronephric ducts, which are used to excrete
waste out the cloaca at the distal end of the pronephric duct. Pronephros development can be
categorized into four stages. Specification begins at 12hpf and is followed by epithelialization of
the pronephric duct between 16-24hpf. Nephron patterning occurs between 30 and 40hpf and
angiogenesis begins at 40hpf (Drummond, 2002; Drummond, 2003). P-CaMK-II was assessed
along the kidney during these established stages of pronephros development. Active CaMK-II is
easily seen at 24hpf, at the end of the epithelialization stage, on the apical side of ciliated cells
lining the pronephric duct and in a cortical pattern in the cloaca (Figure 4.2a). Active CaMK-II is
found within cloacal cilia as demonstrated by co-localization with acetylated tubulin (Figure
4.2b,c, arrowhead), but is not found in ductal cilia. Active CaMK-II is targeted to the membrane
in the cloaca as shown by co-localization with a membrane targeted CAAX:GFP expressing
embryos (Figure 4.2c, arrow).
Activation peaks at 30hpf, at the beginning of nephron patterning, where P-CaMK-II is
found in both apical and basolateral membranes of the proximal pronephric duct and at high
levels in the distal pronephric duct and cloaca (Figure 4.2d-f).
The α1 subunit of Na+K+-ATPase is located in a discontinuous pattern along the
pronephric ducts in transporting epithelial cells and is excluded from multiciliated cells. Active
CaMK-II co-localizes in the basolateral membrane with some Na+K+-ATPase expressing cells.
(Figure 4.2g-i) CaMK-II remains highly active but not diminished in the kidney through 72hpf,
where expression is noticeable in the distal pronephric duct, cloaca, and cloacal cilia (data not
98
shown). Interestingly, there is a loss of active CaMK-II in a small segment towards the distal end
of the pronephric duct, which is first noticeable at 24hpf and persists throughout embryonic
development denoted as a gap in Figure 4.2j.
KN-93 reduces active CaMK-II in the kidney
The specificity of the P-CaMK-II antibody in immunolocalization was evaluated by
incubating embryos in KN-93, a well-characterized CaMK-II inhibitor. KN-93 inhibits CaM
from binding to CaMK-II, thus blocking activation and preventing Thr287 autophosphorylation.
Embryos were continuously treated from cleavage stages with 10 µM KN-93, fixed at 30hpf,
immunolabeled with P-CaMK-II, and imaged. KN-93 treatment visibly reduced the level of
active CaMK-II in the distal pronephric duct and cloaca (Figure 4.3b,c). In addition, Na+K+-
ATPase:GFP embryos were collagenase treated to excise kidneys at 3dpf (Figure 4.3d,e). The
GFP positive pronephric ducts were harvested and assessed for total and P-CaMK-II by
immunoblot. For comparison, 6dpf whole embryo lysates were evaluated. Both 3dpf kidney
lysates and 6dpf embryo lysates show a strong band at approximately 60 kDa representing
endogenous CaMK-II that is enriched in the kidney (Figure 4.3f). Furthermore, highly active
CaMK-II was only evident in the kidney lysate (Figure 4.3g). These results support the
specificity of the P-CaMK-II antibody for activated CaMK-II and suggest that not only is
CaMK-II enriched in the kidney but that it is highly active (see Figure 4.10).
γ1 CaMK-II mRNA is expressed in the kidney
To determine which of the seven CaMK-II genes is present in the pronephric duct during
zebrafish development Na+/K+-ATPase:GFP-transgenic pronephric ducts were either manually
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sorted after collagenase treatment or trypsinized and sorted using a flow cytometer. Manually
sorted pronephric duct cDNA was generated for 24, 48, and 72hpf embryos while flow sorted
pronephric duct cDNA was generated for 48hpf embryos. Gene specific primers were used to
amplify, TOPO clone, and sequence cDNAs to identify which CaMK-II genes and splice
variants were present in the developing pronephros. γ1C was the predominant variant in the
zebrafish kidney, with no γ2, β1, or β2 CaMK-IIs identified in flow sorted cells. These primers
have already been shown to amplify all seven genes (Chapter 2). γ1C is a simple variant,
encoding domains II, VI, and VII in the variable domain and is predicted to be cytosolic (Figure
2.3, Figure 2.4). A second variant, γ1F was identified from manually dissected cDNAs, but absent
from flow isolated cDNAs. γ1F contains domains II, IV/V, VI, VII, VIII/IX in the variable
domain. Domain VIII/IX is thought to contain membrane targeting sequences. The absence of
this variant in flow sorted cells could be due to either mis-timing of expression of this variant
and/or the presence of other tissue in the manually dissected pronephros that is absent in flow
sorted cells.
To verify the expression of camk2g1 in the pronephros, an antisense mRNA probe was
generated against the γ1C variant and whole mount in situ hybridization (WISH) experiments
were performed for 18hpf, 28hpf and 72hpf embryos. Although CNS expression was
predominant, expression in the pronephric duct region was identified at all three time points
(Figure 4.4a-c, arrow). Pronephric duct expression was confirmed at 72hpf in cyrosections
(Figure 4.4c’, arrow).  To verify these results, fluorescent in situ hybridization using the γ1C
probe was combined with immuno-staining of acetylated tubulin in 48hpf wild type embryos
(Figure 4.4d). As shown above, acetylated tubulin was used as a marker for cilia in the
pronephric duct lumen. In addition, double fluorescent in situ hybridization (DFISH) in 72hpf
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wild type fish showed co-localization of camk2g1 with pax2a (Figure 4.4e-g). Pax2a is the
earliest marker of pronephros development and is expressed throughout the pronephric duct
during embryogenesis.  Camk2g1 and pax2a co-localized in pronephric cells, while camk2g1
was also evident in the ventral somites (Figure 4.4g, arrowhead). This mRNA expression pattern
is consistent with the camk2g1 gene encoding CaMK-II in the developing pronephros.
Suppression of γ1 CaMK-II causes cloacal occlusions and cyst formation
Camk2g1 expression was suppressed using the camk2g1 translation-blocking antisense
morpholino oligonucleotide (Table 2.3). Injection of 1 ng caused pericardial edema,
hydrocephaly, cloacal occlusions and pronephric cysts (Figure 4.5a-f).  Injection of higher
concentrations (1.5-3 ng) yielded anterior-posterior axis defects, atrial enlargement, somite
compression, and loss of left-right asymmetry (data not shown). Development of pronephric
cysts could be viewed in whole mount at the level of the third somite, posterior to the pectoral
fins (Figure 4.5c,d, arrowhead). Thin paraffin sections stained with hematoxylin and eosin
confirmed that camk2g1 suppression induced cyst formation (Figure 4.5g,h, asterisk). Cyst
formation has also been observed in several mutants and morphants of proteins important in cilia
and cloacal development. Therefore, cloacal development was assessed in 3dpf camk2g1
morphants using whole mount DIC imaging (n=143) and 73% had visible cloacal occlusions
(Figure 4.5e,f, arrow; Figure 4.6a). To determine if cilia development and assembly was
disrupted, camk2g1 morphant embryos were immunolabeled with an antibody against acetylated
tubulin. Cilia were the proper length as compared to control embryos (control 8.9 µm + 0.3 µm;
g1 morphant 8.5 µm + 0.8µm) (Figure 4.5k,l) and functioned normally in camk2g1 morphants,
as shown by ciliary beating at 3dpf in the pronephric duct (Supplemental Movie 2 and 3).
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Pronephric cilia normally beat in a wave-like fashion, however cloacal cilia beat similar to
shorter cilia of the KV or spinal cord (Supplemental Movie 4) (Kramer-Zucker et al., 2005).  As
shown above, highly active CaMK-II localizes to cloacal cilia and therefore may play a role in
the development of cloacal occlusions in camk2g1 morphants.
 Development of the pronephros depends on the proper anterior migration of pronephric
epithelial cells to form the convoluted proximal segment. This is visible as a hook-like structure
in the anterior region of the pronephros, as shown by Na+/K+-ATPase antibody staining (Figure
4.5i, arrowhead). Previous research has shown that surgical obstruction of the distal segment
blocked proximal migration, abolishing convolution (Vasilyev et al., 2009). To determine if
suppression of camk2g1 inhibited proper anterior convolution, Na+/K+-ATPase:GFP-transgenic
and Na+/K+-ATPase antibody immunolabeled embryos were assessed at 3dpf for pronephric duct
morphology. 87% of pronephric ducts failed to undergo convolution and remained straight and
parallel (Figure 4.5j, Figure 4.6f). In addition, anterior migration can be determined by
measuring the distance from the posterior ear to the anterior pronephric duct. In control embryos
this distance is approximately 200µm at 3dpf. Suppression of camk2g1 increased this distance to
approximately 700um, implying a loss of anterior directed migration (Figure 4.6b).
Specification of the pronephros is not altered in camk2g1 morphants
To determine if early specification or differentiation was altered in camk2g1 morphants,
in situ hybridizations were completed using known pronephric markers including, pax2a, gata3,
ret1, wt1a and cdh17 (Figure 4.7). Expression of pax2a, a paired box transcription factor, is
evident in 14hpf control and morphant embryos (Figure 4.7a,b) demonstrating that even at high
morpholino concentrations progenitor populations are intact (data not shown). At 24hpf, pax2a
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expression persists in control and morphant embryos throughout the pronephros (Figure 4.7c,d).
It is of note that darker expression occurs at the distal end possibly reflective of the cloacal
obstruction (Figure 4.7c,d). Cadherin17 (Cdh17), expression was also analyzed at 24hpf, where
it was expressed in all tubule and duct progenitors in both control and camk2g1 morphants
(Figure 4.7e,f). Since cloacal occlusion was evident using universally expressed markers of
pronephros development, additional probes were used that are expressed in a subset of
pronephric duct cells. To look more closely at the development of the cloaca gata3 reveals
expression in both control and camk2g1 morphants (Figure 4.7g,h). Ret1, a receptor tyrosine
kinase, appears in the collecting ducts (distal pronephric duct) of both control embryos and
morphants (Figure 4.7i,j). Development of anterior structures is very important in generating the
glomerulus, therefore wt1a was used to look at expression of podocyte lineage cells. Podocytes
are thought to play a role in assembling the glomeruluar capillary tuft to enable filtration
(Drummond, 2003). Although wt1a was expressed in camk2g1 morphants, the field of
expression appears expanded at 24hpf (Figure 4.7k,l). By 48hpf the two areas of wt1a expression
migrate to the midline and fuse to form the glomerulus. Suppression of camk2g1 inhibits the
fusion of the wt1a fields, as two separate wt1a population of cells are evident (Figure 4.7m,n).
This result is consistent with a possible reduction of cellular migration due to an obstructed
pronephros.
Otolith development is defective in camk2g1 morphants
Defects in cilia function and assembly cause a myriad of defects including the loss of
left-right asymmetry, hydrocephaly, kidney cysts, and otolith development. Concentration
dependent suppression of camk2g1 generates similar phenotypes. Since P-CaMK-II is highly
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active at the base of kinocilium in the embryonic ear at 30hpf, as shown above, camk2g1
suppression was assessed to identify if activation of camk2g1 was important in embryonic ear
development. Kinocilia are one of two types of microtubule based cilia in the otic vesicle. There
are two pairs of two to three motile kinocilia that beat to form the otoliths. The second type of
cilia is short and immotile and is thought to play a sensory role in the embryonic ear.
As shown above (Figure 4.1), CaMK-II is also activated in the embryonic ear (otic
vesicle) beginning at 24hpf and persisting at the base of the kinocilium until 30hpf (Figure 4.8a).
Suppression of camk2g1 and treatment with KN-93 both decreased P-CaMK-II levels in the otic
vesicle (Figure 4.8b,c).  To verify that embryonic ear development was not diminished due to a
loss of specification or differentiation, the expression of gata3 mRNA was evaluated. Gata3 was
expressed in the otic vesicle of control, camkg1 morphant, and KN-93 treated embryos at 24hpf
(Figure 4.8d-f). Ciliagenesis is important in the proper development of otoliths, as suppression of
cilia assembly proteins leads to ectopic otolith formation (Colantonio et al., 2009). Therefore,
embryos were immunolabeled with acetylated tubulin at 24hpf to evaluate kinocilia length
(Figure 4.8g-i). No discernable difference was identified between control, camk2g1 morphant,
and KN-93 treated embryos (Figure 4.8j). However at 3dpf, camk2g1 morphants that have
ectopic otoliths show an alteration in number and location of kinocilia (data not shown).
Otic vesicle gross morphology was assessed at 3dpf in control, camk2g1 morphant, and
KN-93 treated embryos. More than 95% of control embryos had two otoliths, comprised of an
anterior otolith and a larger posterior otolith (Figure 4.8k). Suppression of camk2g1 (Figure 4.8l-
l-n) and treatment with KN-93 (figure 4.8o,p) caused ectopic and abnormally shaped otoliths to
develop. Often otoliths appeared smaller and fused (Figure 4.8q). Treatment with KN-93 after
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26hpf did not alter otolith formation, pointing to an early requirement for active CaMK-II (data
not shown). Otolith morphology analysis is summarized in Figure 4.8k.
To better understand the development of otoliths, high-speed video microscopy was used
to view the tethered cilia beating and the CaCO3 microcrystals aggregate to form the otoliths.
Two sets of tethered cilia are present opposite each other in a 24hpf embryo. These tethered cilia
can be easily visualized in control embryos (Supplemental movie 7 and 8). The cilia beat
forming a localized vortex to aid in adding CaCO3 microcrystals to the seeded otolith that form at
the tip of the kinocilium (Supplemental movie 9). Suppression of cilia assembly proteins, ift88
and gas8, caused ectopic otoliths to develop because the tethered cilia fail to beat (Colantonio et
al., 2009). Suppression of camk2g1 and KN-93 treatment does seem to alter tethered cilia beating
and also appears to alter the stability of the central kinocilia (Supplemental movies 10-13). The
tethered cilia seem to beat irregularly in some camk2g1 morphants, which may cause the
microcrystals that enter into the vortex to move irregularly as compared to control embryos.
However, the CaCO3 microcrystals continue to move in both camk2g1 morphants and KN-93
treated embryos (Supplemental movies 14). The combination of the instability of the central
kinocilia and the failure of the microcrystals to move correctly may explain the alterations in
otolith development.
Ectopic expression of CaMK-II rescues cyst Development in pkd2 morphants
CaMK-II activation is dependent on Ca2+ entry into the cytosol either through
extracellular or intracellular sources. There are several Ca2+ channels in the ER, plasma
membrane and cilia that could influence the activation of CaMK-II in the kidney. Previous work
in the Tombes lab has demonstrated that knockdown of pkd2 in zebrafish embryos caused a
105
reduction in active CaMK-II around the KV (Francescatto et al., 2010). Since PKD2 is a member
of the TRP superfamily of nonselective Ca2+ permeable channels and is expressed in the kidney,
it is plausible that CaMK-II acts downstream of PKD2 during kidney development.
4.5 ng of a pkd2 translation blocking morpholino was injected alone or co-injected with
either 40ng/ul of cytosolically targeted, GFP tagged wild type or constitutive active (T287D) δE
CaMK-II under the control of the β-actin promoter as described above. Embryos were assessed
at 3dpf for cloacal occlusions, hydrocephaly, and tail curvature through DIC images (Figure
4.9a-c). Approximately 89% of PKD2 morphants developed obstructed pronephric ducts, 97%
had hydrocephaly, and 96% exhibited tail curvature. Ectopic expression of constitutively active,
but not wild type, CaMK-II reversed cloacal obstructions in 46% of embryos (Figure 4.9d-f).
Hydrocephaly and tail curvature could not be rescued as well by overexpression of CaMK-II.
GFP-CaMK-II expressing pkd2 morphants were also assessed for anterior pronephric duct
convolution at 72hpf in Na+/K+-ATPase:GFP embryos or Na+/K+-ATPase antibody
immunolabeled embryos. 5% of pkd2 morphants and 48% of constitutively active CaMK-II
expressing morphants displayed proper convolution, respectively (Figure 4.9g-j).  These results
are summarized in Figure 4.9m.
To complement the rescue, the distance between the posterior otic vesicle and the anterior
pronephric duct was measured, as described above.  Pkd2 morphant pronephric epithelia failed to
migrate anteriorly, as previously reported (Vasilyev et al., 2009), causing a 600µm distance to
form compared to 200µm in control embryos. Ectopic expression of cytosolically targeted
constitutively active CaMK-II partially reduced the distance from the ear to the anterior
pronephric duct to 350µm (Figure 4.9n). Although 52% of pkd2 morphants co-injected with
constitutively active CaMK-II did not show a complete rescue of proximal tubule convolution,
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the pronephric epithelia appeared to migrate anteriorly, as demonstrated by measuring the
distance between the proximal tubule and the posterior otic vesicle. The lack of a complete
rescue could be due to the mosaic expression pattern that results from injection of a cDNA,
where only a subset of pronephric epithelia expressed constitutively active CaMK-II. To address
this issue, mRNA was generated and injected sequentially with 4.5ng of pkd2 morpholino and
assessed at 3dpf. Constitutively active CaMK-II mRNA was degraded rapidly and therefore was
unable to rescue the cystic phenotype (data not shown). Together, these data suggest that CaMK-
II may be the downstream effector of PKD2 Ca2+ in the zebrafish pronephric duct.
Activated CaMK-II is reduced in camk2g1 and Pkd2 morphant embryos
To determine if PKD2 Ca2+ activates CaMK-II, the P-CaMK-II antibody was used in
whole mount embryos and CaMK-II activity assays were completed on manually dissected
pronephros. Since P-CaMK-II activity peaks at 30hpf in the kidney, control, camk2g1 and pkd2
morphants were fixed at 30hpf and levels of P-CaMK-II assessed in the distal pronephric duct.
Control embryos had high levels of active CaMK-II in apical regions of the duct, lower levels in
the basolateral membrane, and clusters of highly active CaMK-II were visible in the cytosol
(Figure 4.10a). Suppression of camk2g1 reduced the level of active CaMK-II in the apical
membrane, with very little P-CaMK-II visible in the basolateral membrane and subcellular
clusters (Figure 4.10b). Knockdown of pkd2 caused a marked reduction of active CaMK-II in the
apical membrane, with a loss of P-CaMK-II in basolateral membranes and clusters (Figure
4.10c). CaMK-II activity assays were also completed on excised pronephric ducts to determine if
CaMK-II autonomy also decreased in pkd2 morphants. In fact, CaMK-II autonomy was
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decreased by approximately 40% in manually excised pronephric cells (Figure 4.10d). These
results point to CaMK-II as the PKD2 Ca2+ target in the zebrafish kidney.
Actin polarity is altered in camk2g1 morphants
Since CaMK-II is known to influence cytoskeletal organization and stabilization, cell
polarity was evaluated in camk2g1 morphants. To examine F-actin, embryos were fixed at 24hpf
and immunolabeled with Alexa488 phalloidin. Control embryos maintained apical localization of
F-actin in the cloaca, while F-actin was mislocalized to both apical and basolateral membranes in
camk2g1 morphants (Figure 4.11a,b). Cell morphology was also altered in the distal end of the
cloaca, where camk2g1 morphant cells failed to become columnar (Figure 4.11b). In the distal
pronephric duct, F-actin appeared slightly disorganized compared to control embryos (Figure
4.11c,d). Similar to other cystic mutants and morphants, camk2g1 knockdown also mislocalized
Na+/K+-ATPase from the basolateral to apical membrane in the proximal pronephric duct (Figure
4.11i,j). Camk2g1 morphants, however, showed proper apical polarity of γ-tubulin, a protein
found in basal bodies, and of the apical membrane marker atypical protein kinase C, aPKC, in
the cloaca and distal pronephric duct (Figure 4.11e-h). These results identify CaMK-II as an
important protein in maintaining the F-actin cytoskeleton in the pronephros, where a loss of
camk2g1 leads to cloacal obstructions and ultimately cyst development.
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DISCUSSION
This study identifies the first direct downstream target of kidney PKD2 Ca2+ and implies
a role for CaMK-II in ADPKD pathology. Suppression of camk2g1 induces cloacal occlusions,
hydrocephaly and pronephric cysts similar to pkd2 morphants. Activation of CaMK-II requires
PKD2 Ca2+ for maintenance of normal renal epithelial cells in the zebrafish since pkd2
morphants have a reduction in active CaMK-II. Camk2g1 morphants have reduced anterior
migration and abnormal actin polarity, pointing to these mechanisms as the principal cause of
cystogenesis in camk2g1 morphants.
Cloacal obstruction and CaMK-II
Development of the cloaca requires cellular proliferation, cell shape changes, and
establishment of apico-basal polarity (Pyati et al., 2006; Vasilyev et al., 2009). Unlike proximal
epithelial cells, cloacal cells do not migrate, however improper cloacal development has been
shown to inhibit proximal pronephric epithelial migration (Vasilyev et al., 2009). The formation
of the cloacal opening requires cells to undergo a cuboidal to columnar cell transformation (Pyati
et al., 2006). Camk2g1 morphant cloacal cells fail to undergo this morphological change and
remain cuboidal.  In addition, the actin cytoskeleton is altered where F-actin is found in both
apical and basolateral membranes, as compared to apical in control embryos. In Xenopus and
Drosophila embryos apical constriction is necessary to alter cell morphology during gastrulation
(Kam et al., 1991; Keller, 1981; Sweeton et al., 1991). Loss of this apical constriction leads to
alterations in cell shape that inhibit proper tissue development (Daggett et al., 2007). F-actin
organization is also lost in arhgef11, a Rho GEF, morphant embryos in which pronephric cysts
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form by 48hpf (Panizzi et al., 2007). The lack of polarity inhibits the morphological changes
necessary to generate the cloacal opening, thereby inducing the formation of pronephric cysts.
PKD1 is also known to interact with E-cadherin complexes, which contain β-catenin,
generating the hypothesis that PKD1 influences β-catenin signaling (Geng et al., 2000; Wilson,
2001). Wnt ligand binding causes β-catenin to dissociate from E-cadherin complexes, then it is
shuttled into the nucleus to influence transcription of TCF/LEF dependent genes (Moon et al.,
2002; St Amand and Klymkowsky, 2001). Tiam1, a Rac GEF and known substrate of CaMK-II,
is necessary to form and maintain cadherin-based adhesions (Malliri et al., 2004). In addition,
primary ADPKD cell culture experiments demonstrated the importance of the E-cadherin/β-
catenin complex, where a loss of adhesion alters renal epithelial function (Charron et al., 2000).
 In addition to its role at adherins junctions, β-catenin is best studied in its role as a
positive regulator of canonical Wnt transcription. Human and rodent cyst tissue upregulates the
expression of c-myc, which is a β-catenin dependent gene, altering renal epithelial proliferation
(Lanoix et al., 1996).  Mouse models that overexpress c-myc develop kidney cysts throughout
their life (Wilson, 2004a). In addition, CaMK-II has been shown to influence β-catenin
transcription through an interaction with flightless-I (Fli-I), an actin binding and capping protein.
Activation of CaMK-II inhibits Fli-I from translocating into the nucleus to inhibit TCF/LEF
dependent transcription (Seward et al., 2008). However, suppression of Pkd2 or camk2g1 does
not appear to alter proliferation of zebrafish pronephric epithelial cells (Obara et al., 2006).
Recent research has determined that Fli-I also influences actin assembly through a
Diaphenous related formin protein, mDia. mDia is the mammalian Diaphanous homolog1 and is
thought to bind to Fli-I to enhance actin assembly (Higashi et al.). Therefore, it is possible
CaMK-II forms a complex with Fli-I and mDia to regulate actin assembly in the zebrafish
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pronephric duct. CaMK-II also binds to F-actin in P19 neurons, where inhibition of CaMK-II
causes F-actin disorganization and reduced neurite outgrowth (Easley et al., 2006).
CaMK-II and pronephric epithelial cellular migration
Zebrafish pronephros development requires migration of the pronephric epithelia to form
the embryonic kidney. Collective cell migration begins at 28.5hpf, coincident with highly active
CaMK-II in the proximal pronephric duct, where pronephric epithelial cells undergo a proximal-
directed migration toward the glomerulus. This migration occurs as a sheet, where apical cell
connections are maintained and basal surfaces project lamellipodia at the leading edge under the
cell in front. Cells that were migratory stained positive for phospho-FAK, demonstrating
adhesion to the basement membrane and the requirement for focal adhesion turnover (Vasilyev
et al., 2009). The inactivation of focal-adhesion complex proteins, such as PKD1 and tensin,
leads to the development of cysts in mice (Lo et al., 1997; Wilson, 2004b). Suppression of
camk2g1 and Pkd2 inhibited proper pronephric duct migration and anterior convolution, whereas
pkd2 morphants ectopically expressing constitutively active CaMK-II partially recovered cellular
migration.
CaMK-II and PKD1 have been identified at focal adhesions (Easley et al., 2008; Wilson
et al., 1999). PKD2 forms a receptor channel complex with PKD1, where PKD1 interacts with
the extracellular matrix (ECM) and focal adhesion proteins (Wilson, 2004a; Wilson, 2008).
ADPKD patients that have mutations in PKD1 have increased adhesiveness to the ECM and
decreased motility, this is identical to studies where CaMK-II is acutely inhibited in mouse
fibroblasts (Easley et al., 2008; Wilson et al., 1999). Focal adhesion turnover requires the
dephosphorylation of tyrosine residues on paxillin and FAK (Mitra et al., 2005). PKD1 co-
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localizes with paxillin in renal cell culture, demonstrating a possible link between PKD1 and
CaMK-II at focal adhesions (Israeli et al., ; Wilson, 2001). CaMK-II also influences cell motility
through the phosphorylation of Tiam1 to activate Rac and enable cells to secrete ECM proteins
for adhesion and migration (Fleming et al., 1999). Therefore the lack of migration in proximal
epithelial cells in Pkd2 and camk2g1 morphants could be due to the inhibition of CaMK-II at
focal adhesions.
Alternative CaMK-II substrates during kidney development
mDia also functions to inhibit PKD2 channel activity under resting potentials, where
mDia remains in the autoinhibited conformation. Upon EGFR activation a conformation change
occurs in mDia allowing for channel activation and Ca2+ entry into the cytosol of LLC-PK1
kidney epithelial cells (Bai et al., 2008). CaMK-II is known to phosphorylate proteins to alter
intracellular Ca2+ concentrations, either directly or indirectly to influence cellular mechanisms. In
the heart CaMK-II phosphorylates ryanodine receptors to release Ca2+ from the ER and
phosphorylates phospholamban to initiate reuptake of Ca2+ back into the ER through SERCA
(Maier, 2009). This process allows for excitation-contraction coupling in the heart.  PKD2 has
structural similarities to voltage-activated L-type Ca2+ channels, a known substrate of CaMK-II
(Grueter et al., 2006; Mochizuki et al., 1996). Although CaMK-II has not been shown to
phosphorylate PKD2, several CaMK-II consensus sites are located throughout the PKD2
sequence.
Histone deacetylases (HDAC) have become a therapeutic target in cancer treatment,
where inhibition of HDACs allow transcription of genes normally downregulated. Recent
research has demonstrated that HDAC5 may also be a viable target in treating ADPKD.
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HDAC5, a class II histone deacetylase, is phosphorylated in a Ca2+-dependent manner and then
shuttled to the cytosol. As a result MEF2C target genes are activated, including missing in
metastasis (MIM), which is involved in actin cytoskeletal dynamics.  Mef2c knockout mice and
MIM-deficient mice develop tubule dilations and cysts, while inhibition of HDAC5 in Pkd2-/-
mice suppresses renal cyst formation (Xia et al.). Similarly, in the heart CaMK-II phosphorylates
HDAC4, also a class II histone deacetylase, which retains HDAC4 in the cytosol to upregulate
MEF2C target genes (Little et al., 2007; Zhang et al., 2007). These results identify CaMK-II as
the possible effector protein activated by PKD2 Ca2+ to phosphorylate HDAC5 to maintain
normal renal development.
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Figure 4.1. CaMK-II localizes to the CNS, somites, embryonic ear and kidney. Total CaMK-
II (a,e,i,m) and P-CaMK-II (b,f,j,n) co-localize in the forebrain (a-c,), spinal cord cell bodies, (e-
g, arrowhead in g), muscle sarcomeres and apical membranes of the kidney (i-k) and embryonic
ear (m-o) at 30hpf. P-CaMK-II co-localizes with acetylated tubulin in some cells and axons in
the forebrain (d) and in spinal cord cell bodies, but is undetectable from spinal cord axons (h).  P-
CaMK-II localizes cortically in cloacal cells but does not co-localize with pronephric duct cilia
(l). Active CaMK-II is enriched at the base of the hair cell kinocilium (p, arrowhead), but is also
cytosolically enriched in these cells. Scale bars= 10 µm.
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Figure 4.2. Differential activation of CaMK-II in the kidney.
(a-c) Active CaMK-II is first evident at 24hpf in the pronephric ducts, cloaca and cilia. P-
CaMK-II co-localizes with acetylated tubulin in cloacal cilia but is absent from pronephric duct
cilia (b,c, arrowhead). Cortical localization of P-CaMK-II is confirmed by co-localization with
membrane bound GFP (c, arrow).
(d-i) Activated kidney CaMK-II peaks at 30hpf. Proximal pronephric duct localization of
P-CaMK-II is both apical and basolateral but also found in distinct cytosolic clusters (d,f,
asterisk). High levels of apical P-CaMK-II are evident in the distal pronephric duct and cloaca
(e,f).
(g-i) P-CaMK-II is found in transporting epithelial cells as demonstrated by co-
localization with an antibody against the kidney specific α1 subunit of Na+K+-ATPase.  (j)
Active CaMK-II is absent from a small section of the intermediate pronephric duct from 24hpf-
72hpf. Scale bar=10 µm.
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Figure 4.3. KN-93 inhibits activation of CaMK-II in the kidney.  (a-c, Scale bar=0.5mm)
Whole mount images of P-CaMK-II immunolabeled embryos treated with either DMSO control
(a,b) or 10 µm KN-93 (c). 72hpf dissected Na+K+-ATPase:GFP positive pronephric duct (d,e;
arrow is the cloaca, Scale bar=100 µm). Total-CaMK-II and P-CaMK-II immunoblot of 6dpf
zebrafish compared to 72hpf dissected pronephros lysate using 4µg of protein (f,g).
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Figure 4.4. Camk2g1 mRNA is expressed in the kidney. (a-c) WISH experiments were
completed using γ1C probe on 16s 28hpf, and 72hpf wild type embryos, (pronephros denoted by
arrow in b,c,c’) and (c’) 72hpf embryos were cryosectioned.  (d) FISH of 48hpf embryos with
γ1C probe followed by immunostaining with acetylated tubulin to demarcate pronephric tubule
cilia. (e-g) Double FISH demonstrates that γ1C mRNA (e, Cy3) and kidney marker, pax2a (f,
Alexa 488) co-localize (g) in the distal pronephric duct. Scale bar = 0.5mm.
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Figure 4.5. Suppression of camk2g1 induces kidney cyst formation. Control (a,e,g,I,k) and
camk2g1 morphant (b-d,f,h,j,l) embryos at 72hpf. Camk2g1 morphant embryos develop
hydrocephaly (b, arrow; Scale bar=0.5 mm), pericardial edema (b, arrowhead), cysts (c,d,
arrowhead; Scale bar=100 µm) and cloacal occlusions (e,f, arrow; Scale bar=100 µm) by 72hpf.
Thin paraffin sections stained with hematoxylin and eosin identify cysts (g,h, asterisks).
Improper proximal pronephric tubule convolution is assessed by α6F Na+K+ATPase
immunolabeling at 72hpf (i,j; Scale bar=50 µm) Cilia are identified by acetylated tubulin
immunolabeling at 24hpf (k,l; Scale bar=10µm).
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Figure 4.6. Anterior and posterior kidney defects in camk2g1 morphants. Cloacal
development was assessed to determine if a cloacal opening forms by 72hpf (a; Figure 4.5e,f).
Anterior convolution was determined by the presence of a “hook” in the anterior pronephros (a;
Figure 4.5i,j). Migration of the anterior pronephros was determined by the measurement from the
posterior embryonic ear to the anterior pronephros (b; inset).
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Figure 4.7. Pronephros specification is not altered in camk2g1 morphants. WISH of control
and camk2g1 morphants using pax2a at 14 somites (dorsal view; a,b) pax2a, cdh17, gata3, ret1,
at 24hpf (c-j; lateral view, anterior to the left) wt1a at 24hpf (k,l) and 48hpf (m,n; dorsal view).
Pronephros depiction modified from (Wingert et al., 2007) to identify the region of expression
for each probe G=glomerulus, PCT=proximal convoluted tubule, PD=pronephric duct, C=cloaca
(o; dorsal view).
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Figure 4.8. Otolith development is defective in camk2g1 morphants. Activated CaMK-II is
reduced in camk2g1 morphants and KN-93 treated embryos at 24hpf (a-c; Scale bar=5 µm). Otic
vesicle specification is not altered in camk2g1 morphants or KN-93 incubated embryos as
assessed using gata3 ISH (d-f; dorsal view Scale bar=100 µm). Kinocilia in morphants are the
same length as control embryos (g-j; Scale bar=5 µm).  Gross morphology of the otoliths was
assessed at 3dpf and found to be abnormal in camk2g1 morphants (l-n) and KN-93 treated (o,p)
embryos compared to control (k; Scale bar=50 µm). Otolith fusion (l,p; arrowhead), and ectopic
otolith formation (m,n,o; arrow) occur often in knockdown embryos. Over 90% of camk2g1
morphant  and over 60% of KN-93 treated embryo otoliths are abnormal (q).
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Figure 4.9. Ectopic constitutively active CaMK-II reverses cyst development in pkd2
morphants. Lateral view of control, pkd2 morphant, and pkd2 morphant embryos co-injected
with constitutively active (T287D) human δE CaMK-II at 72hpf (a-c; Scale bar=1 mm). Cloacal
occlusions are rescued with ectopic CaMK-II expression (e,f,m; Scale bar=100 µm). Cilia
formation is normal (g-i; Scale bar=10 µm) and anterior convolution is rescued (h-j,m; Scale
bar=50 µm) assessed using acetylated tubulin and α6F Na+K+-ATPase immunostaining. Anterior
migration is restored to near normal levels in constitutively active CaMK-II expressing pkd2
morphants (n).
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Figure 4.10. Activated CaMK-II is reduced in camk2g1 and pkd2 morphants. P-CaMK-II is
reduced in the apical membrane (arrowhead), basolateral membrane (arrow), and cytosolic
clusters (asterisk) of cam2g1 and pkd2 morphants. CaMK-II calcium independent activity is
reduced in pkd2 morphant dissected pronephros at 72hpf (d). Scale bar=10 µm
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Figure 4.11. Actin polarity and organization is altered in camk2g1 morphants. Actin
localization was assessed using Phalloidin immunolabeling where control embryos have strong
apical F-actin (a, arrow) and camk2g1 morphants have strong apical and basolateral (b,
arrowhead) F-actin localization in the cloaca.  Actin is correctly localized in the distal pronephric
duct of camk2g1 morphants however the apical F-actin appears disorganized (c,d; Scale bar=10
µm). aPKC and γtubulin are correctly localized to the apical membrane in both the cloaca (e,f)
and distal pronephric duct (g,h; Scale bar=20 µm). Cryosectioned α6F Na+K+-ATPase
immunolabeled embryos show loss of basolateral expression as well as the formation of cysts
(i,j; Scale bar=10 µm).
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Figure 4.12. Model of CaMK-II in PKD2 Morphants. CaMK-II activation is important for
many cellular processes.  1. CaMK-II is important for cell motility by promoting focal adhesion
turnover. In pkd2 and camk2g1 morphants proximal migration is inhibited, possibly due to the
inhibition of focal adhesion turnover.  2. CaMK-II binds to Fli-I to promote actin assembly and
stabailization and suppression of pkd2 could alter this relationship influencing actin stability and
polarity. 3. Cytosolic localization of HDAC5 promotes transcription of MEF2 target genes, in
animal models of ADPKD HDAC5 is not retained in the cytosol inhibiting transcription of genes
important in normal renal development.
1
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Supplemental Movies
Supplemental Movie 3 – Video shows control kidney cilia beating at 72hpf, arrows.
Supplemental Movie 4 – Video shows zoom of cloacal cilia beating at 72hpf, arrows.
Supplemental Movie 5 – Video shows camk2g1 kidney cilia beating at 72hpf, arrowns.
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Supplemental Movie 6 – Video shows KN-93 kidney cilia beating at 72hpf, arrows.
Supplemental Movie 7 – Video shows control tether cilia beating at 24hpf, arrow.
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Supplemental Movie 8 – Video shows zoom of control tether cilia beating at 24hpf, arrow.
Supplemental Movie 9 – Video shows CaCO3 microcrystals in control 24hpf embryo.
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Supplemental Movie 10 –Video shows camk2g1 morphant tether cilia beating irregularly (arrow)
and altered otolith movement at 24hpf.
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Supplemental Movie 11–Video shows camk2g1 morphant CaCO3 microcrystals and lack of
tether cilia beating at 24hpf.
Supplemental Movie 12–Video shows camk2g1 morphant CaCO3  microcrystals and lack of
tether cilia beating at 24hpf.
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Supplemental Movie 13–Video shows entire otic placode with CaCO3 microcrystals.
Supplemental Movie 14 – Video shows CaCO3 mirocrystal and lack of tether cilia beating in
KN-93 treated 24hpf embryos.
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Chapter 5: Dissertation Summary
This study is the first to comprehensively analyze the expression and role of CaMK-II
genes in vivo. Zebrafish are an ideal model system to analyze signaling proteins, such as CaMK-
II, during development because of the transparency of the embryo, rapid development, external
fertilization, and experimental techniques available. Interestingly, zebrafish retain 75% of the
duplicated CaMK-II genes yielding a total of 7 catalytically active and 1 catalytically inactive,
α1KAP, CaMK-II. The retention and transcription of these genes during embryogenesis
demonstrates the importance of this signaling molecule in zebrafish development.
Although the studies presented here specifically address camk2b2 and camk2g1,
suppression of all seven genes result in unique identifiable phenotypes by 48hpf and reduced
CaMK-II activity. Suppression of camk2b2 causes bradycardia, reduced circulation, and inhibits
proper pectoral fin and heart development. This phenotype is reminiscent of the tbx5 morphant
and tbx5 mutant (hst), which is the gene mutated in patients with Holt-Oram Syndrome (also
known as heart-hand syndrome). CaMK-II activity decreased significantly by 72hpf and β2
mRNA expression was reduced in tbx5 morphant and mutant hearts and fins. Overexpression of
Tbx5 in mouse NIH/3T3 fibroblasts and in zebrafish embryos caused an increase in CaMK-II
activity. These results identify Tbx5 as a positive regulator of β2 CaMK-II expression in the
zebrafish heart and kidney. Although Tbx5 upregulates transcription of many genes,
understanding the downstream pathways in Tbx5 mutations will help in identifying possible
treatments for patients with HOS.
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Camk2g1 was the second gene analyzed in this study due to its unique expression pattern
in the developing zebrafish kidney (pronephros). Suppression of camk2g1 leads to hydrocephaly,
otolith defects, cloacal occlusions and pronephric cysts. This phenotype mirrors that seen in pkd2
and pkd1 morphants, both zebrafish models of autosomal dominant polycystic kidney disease.
Mutations in either PKD1 or PKD2 cause ADPKD, which is the most common kidney
syndrome. Although much is known about the condition, the immediate downstream effector of
PKD2 Ca2+ is unknown. This study identifies CaMK-II as this downstream effector, where
ectopic constitutively active CaMK-II partially rescues the pkd2 morphant cystic phenotype. In
addition, activation of CaMK-II is reduced in pkd2 morphant embryos and dissected kidneys.
These results implicate CaMK-II in ADPKD pathology and identify the first Ca2+-dependent
effector protein that has altered activity in a vertebrate model of ADPKD.
CaMK-II is the ideal signaling molecule during development, where it is important for
cell movements during gastrulation, pectoral fin and heart morphogenesis, excitation-contraction
coupling, kidney development, and otolith formation.  Future research in the zebrafish should
provide additional insight into the role of this multifunctional signaling hub in understanding
basic developmental biology in addition to human pathologies.
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